Strongyloidiasis with emphasis on human infections and its different clinical forms

Advances in Parasitology

Volumn 88, Issue , 2015, Pages 165-241

  Toledo, Rafael ^a   Muñoz Antoli, Carla ^a   Esteban, José Guillermo ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Chronic strongyloidiasis; Hyperinfection; Severe strongyloidiasis; Strongyloides fuelleborni; Strongyloides stercoralis; Strongyloidiasis

Indexed keywords

ANTHELMINTIC AGENT; CORTICOSTEROID; VACCINE; VINCRISTINE;

ABDOMINAL PAIN; ANIMAL MODEL; ANOREXIA; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ANTIMICROBIAL THERAPY; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFRACTION BASED BIOSENSOR TECHNOLOGY; DIPSTICK ASSAY; DISEASE COURSE; DISEASE SEVERITY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; GENOMICS; GEOGRAPHIC DISTRIBUTION; HEARTBURN; HEMOPTYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; IATROGENIC DISEASE; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPRECIPITATION; INDIGESTION; INFECTION CONTROL; INFECTION RISK; LABORATORY DIAGNOSIS; LARVAL STAGE; MICROBIAL MORPHOLOGY; MIXED INFECTION; MOLECULAR DIAGNOSIS; MORPHOLOGICAL TRAIT; NAUSEA; NAUSEA AND VOMITING; NEMATODE LIFE CYCLE STAGE; NONHUMAN; OPTICAL BIOSENSOR; PARASITE IMMUNITY; PARASITE PREVALENCE; PARASITOLOGY; PETECHIA; PRIORITY JOURNAL; PROTEOMICS; PRURITUS; SKIN INFECTION; STRONGYLOIDES; STRONGYLOIDES FUELLEBORNI; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; URTICARIA; WHEEZING; ANIMAL; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; RISK FACTOR;

STRONGYLOIDES FUELLEBORNI; STRONGYLOIDES STERCORALIS; VERMES;

ANIMALS; HUMANS; RISK FACTORS; STRONGYLOIDES; STRONGYLOIDIASIS; VACCINES;

EID: 84928212941     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apar.2015.02.005     Document Type: Article

References (462)

1. Abdelrahman M.Z., Zeehaida M., Rahmah N., Norsyahida A., Madihah B., Azlan H., Nazlee W.Z. Fatal septicemic shock associated with Strongyloides stercoralis infection in a patient with angioimmunoblastic T-cell lymphoma: a case report and literature review. Parasitol. Int. 2012, 61:508-511.
2. Abraham D., Hess J.A., Mejia R., Nolan T.J., Lok J.B., Lustigman S., Nutman T.B. Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice. Vaccine 2011, 29:8134-8140.
3. Abraham D., Rotman H.L., Haberstroh H.F., Yutanawiboonchai W., Brigandi R.A., Leon O., Nolan T.J., Schad G.A. Strongyloides stercoralis: protective immunity to third-stage larvae inBALB/cByJ mice. Exp. Parasitol. 1995, 80:297-307.
4. Adenusi A.A., Oke A.O., Adenusi A.O. Comparison of ivermectin and thiabendazole in the treatment of uncomplicated human Strongyloides stercoralis infection. Afr. J. Biotechnol. 2003, 2:465-469.
5. Agarwal V.K., Khurana H.S., Le H.X., Mathisen G., Kamangar N. 30-Year-old HIV-positive female with diffuse alveolar hemorrhage. J. Intensive Care Med. 2009, 24:200-204.
6. Ahmadi N.A., Damraj F.A. A field evaluation of formalin-gasoline technique in the concentration of stool for detection of intestinal parasites. Parasitol. Res. 2009, 104:553-557.
7. Al Samman M., Haque S., Long J.D. Strongyloidiasis colitis: a case report and review of the literature. J. Clin. Gastroenterol. 1999, 28:77-80.
8. Albonico M., Crompton D.W., Savioli L. Control strategies for human intestinal nematode infections. Adv. Parasitol. 1999, 42:277-341.
9. Alexander C.L., Clutterbuck D.J., Jones B. Strongyloides stercoralis: highlighting an imported case of the neglected parasite. Int. J. STD AIDS 2013, 24:73-74.
10. Allen A.V.H., Ridley D.S. Further observations on the formol-ether concentration technique for faecal parasites. J. Clin. Pathol. 1970, 23:545-546.
11. Altintop L., Cakar B., Hokelek M., Bektas A., Yildiz L., Karaoglanoglu M. Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report. Ann. Clin. Microbiol. Antimicrob. 2010, 9:27.
12. Alver O., Ozakin C., Töre O. The distribution of intestinal parasites detected in the Uludag University Medical Faculty Hospital between 2009-2010. Turk. Parazitol. Derg. 2012, 36:17-22.
13. Anamnart W., Pattanawongsa A., Intapan P.M., Maleewong W. Factors affecting recovery of Strongyloides stercoralis larvae: an approach to a newly modified formalin-ether concentration technique for diagnosis of strongyloidiasis. J. Clin. Microbiol. 2010, 48:97-100.
14. Anamnart W., Pattanawongsa A., Intapan P.M., Maleewong W. Albendazole stimulates the excretion of Strongyloides stercoralis larvae in stool specimens and enhances sensitivity for diagnosis of strongyloidiasis. J. Clin. Microbiol. 2010, 48:4216-4220.
15. Anderson N.W., Klein D.M., Dornink S.M., Jespersen D.J., Kubofcik J., Nutman T.B., Merrigan S.D., Couturier M.R., Theel E.S. Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis. Clin. Vaccine Immunol. 2014, 21:732-736.
16. Anderson R.C. Nematode Parasites of Vertebrates: Their Development and Transmission 2000, CABI Publishing, Oxford.
17. Arakaki T., Iwanaga M., Kinjo F., Saito A., Asato R., Ikeshiro T. Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. J. Parasitol. 1990, 76:425-428.
18. Arango C., Arango C., Seas C. A 29-year-old renal transplant recipient with acute respiratory failure. Am. J. Trop. Med. Hyg. 2012, 86:911-912.
19. Ash L.R., Orihel T.C. Parasites: A Guide to Laboratory Procedures and Identification 1991, ASCP Press, American Society of Clinical Pathologists, Chicago.
20. Ashford R.W., Barnish G., Viney M.E. Strongyloides fuelleborni kellyi: Infection and disease in Papua New Guinea. Trends Parasitol. 1992, 8:314-318.
21. Ashford R.W., Barnish G.B. Strongyloides fuelleborni and similar parasites in animals. Strongyloidiasis a Major Roundworm Infection of Man 1989, 271-286. Taylor and Francis, London. D.I. Grove (Ed.).
22. Asma I., Johari S., Sim B.L., Lim Y.A. How common is intestinal parasitism in HIV-infected patients in Malaysia?. Trop. Biomed. 2011, 28:400-410.
23. Assis E.M., Olivieria R.C., Moreira L.E., Pena J.L., Rodrigues L.C., Machado-Coelho G.L. Prevalence of intestinal parasites in the Maxakali indigenous community in Minas Gerais, Brazil, 2009. C. S. P. 2013, 29:681-690.
24. Atkins N.S., Conway D.J., Lindo J.F., Bailey J.W., Bundy D.A.P. L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlation with larval output. Parasite Immunol. 1999, 21:517-526.
25. Atkins N.S., Lindo J.F., Lee M.G., Conway D.J., Bailey J.W., Robinson R.D., Bundy D.A. Humoral responses in human strongyloidiasis: correlations with infection chronicity. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:609-613.
26. Atul S., Ajay D., Ritambhara N., Harsh M., Ashish B. An unusual cause of malabsorption in an immunocompetent host. J. Ayub. Med. Coll. Abbottabad 2005, 17:85-86.
27. Badaró R., Carvalho E.M., Santos R.B., Gam A.A., Genta R.M. Parasite-specific humoral responses in different clinical forms of strongyloidiasis. Trans. R. Soc. Trop. Med. Hyg. 1987, 81:149-150.
28. Bailey J.W. A serological test for the diagnosis of Strongyloides antibodies in ex Far East Prisoners of War. Ann. Trop. Med. Parasitol. 1989, 83:241-247.
29. Barker E., Mackewicz C.E., Levy J.A. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc. Natl. Acad. Sci. USA 1995, 92:11135-11139.
30. Barnish G., Ashford R.W. Strongyloides cf fuelleborni in Papua New Guinea: epidemiology in an isolated community, and results of an intervention study. Ann. Trop. Med. Parasitol. 1989, 83:499-506.
31. Barnish G., Ashford R.W. Strongyloides cf. fuelleborni and other intestinal helminths in Papua New Guinea: distribution according to environmental factors. Parassitologia 1990, 32:245-263.
32. Basile A., Simzar S., Bentow J., Antelo F., Shitabata P., Peng S.K., Craft N. Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression. J. Am. Acad. Dermatol. 2010, 63:896-902.
33. Basuni M., Muhi J., Othman N., Verweij J.J., Ahmad M., Miswan N., Rahumatullah A., Aziz F.A., Zainudin N.S., Noordin R. A pentaplex real-time polymerase chain reaction assay for detection of four species of soil-transmitted helminths. Am. J. Trop. Med. Hyg. 2011, 84:338-343.
34. Beal C.B., Viens P., Grant R.G., Hughes J.M. A new technique for sampling duodenal contents: demonstration of upper small-bowel pathogens. Am. J. Trop. Med. Hyg. 1970, 19:349-352.
35. Becker S.L., Sieto B., Silué K.D., Adjossan L., Koné S., Hatz C., Kern W.V., N'Goran E.K., Utzinger J. Diagnosis, clinical features, and self-reported morbidity of Strongyloides stercoralis and hookworm infection in a co-endemic setting. PLoS Negl. Trop. Dis. 2011, 5(8):e1292. 10.1371/journal.pntd.0001292.
36. Bethony J., Brooker S., Albonico M., Geiger S.M., Loukas A., Diemert D., Hotez P.J. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006, 367:1521-1532.
37. Biggs B.A., Caruana S., Mihrshadi S., Jolley D., Leydon J., Chea L., Nuon S. Management of chronic strongyloidiasis in immigrants and refugees: is serological testing useful?. Am. J. Trop. Med. Hyg. 2009, 80:788-791.
38. Bisoffi Z., Buonfrate D., Angheben A., Boscolo M., Anselmi M., Marocco S., Monteiro G., Gobbo M., Bisoffi G., Gobbi F. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. PLoS Negl. Trop. Dis. 2011, 5(7):e1254. 10.1371/journal.pntd.0001254.
39. Bisoffi Z., Buonfrate D., Montresor A., Requena-Méndez A., Muñoz J., Krolewiecki A.J., Gotuzzo E., Mena M.A., Chiodini P.L., Anselmi M., Moreira J., Albonico M. Strongyloides stercoralis: a plea for action. PLoS Negl. Trop. Dis. 2013, 7:e2214.
40. Bisoffi Z., Buonfrate D., Sequi M., Mejia R., Cimino R.O., Krolewiecki A.J., Albonico M., Gobbo M., Bonafini S., Angheben A., Requena-Mendez A., Muñoz J., Nutman T.B. Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection. PLoS Negl. Trop. Dis. 2014, 8:e2640.
41. Blagg W., Schloegel E.L., Mansour N.S., Khalaf G.I. A new concentration technic for the demonstration of protozoa and helminth eggs in feces. Am. J. Trop. Med. Hyg. 1955, 4:23-28.
42. Blaxter M.L., De Ley P., Garey J.R., Liu L.W., Scheldeman P., Vierstraete A., Vanfleteren J.R., Mackey L.Y., Dorris M., Frisse L.M., Vida J.T., Thomas W.K. A molecular evolutionary framework for the phylum Nematoda. Nature 1998, 392:71-75.
43. Boaitey Y.A., Nkrumah B., Idriss A., Tay S.C. Gastrointestinal and urinary tract pathogenic infections among HIV seropositive patients at the Komfo Anokye Teaching Hospital in Ghana. BMC Res. Notes 2012, 5:454.
44. Boken D.J., Leoni P.A., Preheim L.C. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clin. Infect. Dis. 1993, 16:123-126.
45. Bollela V.R., Feliciano C., Teixeira A.C., Junqueira A.C., Rossi M.A. Fulminant gastrointestinal hemorrhage due to Strongyloides stercoralis hyperinfection in an¡ AIDS patient. Rev. Soc. Bras. Med. Trop. 2013, 46:111-113.
46. Bon B., Houze S., Talabani H., Magne D., Belkadi G., Develoux M., Senghor Y., Chandenier J., Ancelle T., Hennequin C. Evaluation of a rapid enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis. J. Clin. Microbiol. 2010, 48:1716-1719.
47. Bonne-Année S., Hess J.A., Abraham D. Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model. Immunol. Res. 2011, 51:205-214.
48. Bonne-Année S., Kerepesi L.A., Hess J.A., O'Connell A.E., Lok J.B., Nolan T.J., Abraham D. Human and mouse macrophages collaborate with neutrophils to kill larval Strongyloides stercoralis. Infect. Immun. 2013, 81:3346-3355.
49. Bonne-Année S., Kerepesi L.A., Hess J.A., Wesolowski J., Paumet F., Lok J.B., Nolan T.J., Abraham D. Extracellular traps are associated with human and mouse neutrophil and macrophage mediated killing of larval Strongyloides stercoralis. Microbes Infect. 2014, 16:502-511.
50. Boonjaraspinyo S., Boonmars T., Kaewsamut B., Ekobol N., Laummaunwai P., Aukkanimart R., Wonkchalee N., Juasook A., Sriraj P. A cross-sectional study on intestinal parasitic infections in rural communities, northeast Thailand. Korean J. Parasitol. 2013, 51:727-734.
51. Boscolo M., Gobbo M., Mantovani W., Degani M., Anselmi M., Monteiro G.B., Marocco S., Angheben A., Mistretta M., Santacatterina M., Tais S., Bisoffi Z. Evaluation of an indirect immunofluorescence assay for strongyloidiasis a tool for diagnosis and follow-up. Clin. Vaccine Immunol. 2007, 14:129-133.
52. Boulware D.R., Stauffer W.M., Hendel-Paterson B.R., Rocha J.L., Seet R.C., Summer A.P., Nield L.S., Supparatpinyo K., Chaiwarith R., Walker P.F. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am. J. Med. 2007, 120. 545.e1-8.
53. Brandt de Oliveira R., Voltarelli J.C., Meneghelli U.G. Severe strongyloidiasis associated with hypogammaglobulinaemia. Parasite Immunol. 1981, 3:165-169.
54. Brannon M.J., Faust E.C. Preparation and testing of a specific antigen for diagnosis of human strongyloidiasis. Am. J. Trop. Med. Hyg. 1949, 29:229-239.
55. Brigandi R.A., Rotman H.L., Nolan T.J., Schad G.A., Abraham D. Chronicity inStrongyloides stercoralis infections: dichotomy of the protective immune response to infective and autoinfective larvae in a mouse model. Am. J. Trop. Med. Hyg. 1997, 56:640-646.
56. Brigandi R.A., Rotman H.L., Yutanawiboonchai W., Leon O., Nolan T.J., Schad G.A., Abraham D. Strongyloides stercoralis: role of antibody and complement in immunity to the third stage of larvae in BALB/cByJ mice. Exp. Parasitol. 1996, 82:279-289.
57. Buonfrate D., Mena M.A., Angheben A., Requena-Mendez A., Muñoz J., Gobbi F., Albonico M., Gotuzzo E., Bisoffi Z. Prevalence of strongyloidiasis in Latin America: a systematic review of the literature. Epidemiol. Infect. 2014, 3:1-9. (the COHEMI Project Study Group).
58. Buonfrate D., Requena-Mendez A., Angheben A., Muñoz J., Gobbi F., Van Den Ende J., Bisoffi Z. Severe strongyloidiasis: a systematic review of case reports. BMC Infect. Dis. 2013, 13:78. 10.1186/1471-2334-13-78.
59. Cahill K.M., Shevchuk M. Fulminant, systemic strongyloidiasis in AIDS. Ann. Trop. Med. Parasitol. 1996, 90:313-318.
60. Carp N.Z., Nejman J.H., Kelly J.J. Strongyloidiasis. An unusual cause of colonic pseudopolyposis and gastrointestinal bleeding. Surg. Endosc. 1987, 1:175-177.
61. Carroll S.M., Karthigasu K.T., Grove D.I. Serodiagnosis of human strongyloidiasis by an enzyme-linked immunosorbent assay. Trans. R. Soc. Trop. Med. Hyg. 1981, 75:706-709.
62. Carvalho E.M., Andrade T.M., Andrade J.A., Rocha H. Immunological features in different clinical forms of strongyloidiasis. Trans. R. Soc. Trop. Med. Hyg. 1983, 77:346-349.
63. Carvalho E.M., Porto D.F.A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol. 2004, 26:487-497.
64. Castelletto M.L., Massey H.C., Lok J.-B. Morphogenesis of Strongyloides stercoralis infective larvae requires the DAF-16 ortholog FKTF-1. PLoS Pathog. 2009, 5:e1000370.
65. Celedon J.C., Mathur-Wagh U., Fox J., Garcia R., Wiest P.M. Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literature. Med. Baltim. 1994, 73:256-263.
66. Chaudhuri B., Nanos S., Soco J.N., McGrew E.A. Disseminated Strongyloides stercoralis infestation detected by sputum cytology. Acta Cytol. 1980, 24:360-362.
67. Checkley A.M., Chiodini P.L., Dockrell D.H., Bates I., Thwaites G.E., Booth H.L., Brown M., Wright S.G., Grant A.D., Mabey D.C., Whitty C.J., Sanderson F., British Infection Society and Hospital for Tropical Diseases Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J. Infect. 2010, 60:1-20.
68. Chen R.F., Lai C.P. Clinical characteristics and treatment of constrictive pericarditis in Taiwan. Circ. J. 2005, 69:458-460.
69. Chiodini P.L., Reid A.J., Wiselka M.J., Firmin R., Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet 2000, 355:43-44.
70. Chokkalingam Mani B., Mathur M., Clauss H., Alvarez R., Hamad E., Toyoda Y., Birkenbach M., Ahmed M. Strongyloides stercoralis and organ transplantation. Case Rep. Transplant. 2013, 549038.
71. Choudhry U., Choudhry R., Romeo D.P., Cammerer R.C., Gopalswamy N. Strongyloidiasis: new endoscopic findings. Gastrointest. Endosc. 1995, 42:170-173.
72. Cirioni O., Giacometti A., Burzacchini F., Balducci M., Scalise G. Strongyloides stercoralis first-stage larvae in the lungs of a patient with AIDS: primary localization or a noninvasive form of dissemination?. Clin. Infect. Dis. 1996, 22:737.
73. Concha R., Harrington W., Rogers A.I. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J. Clin. Gastroenterol. 2005, 39:203-211.
74. Conlan J.V., Khamlome B., Vongxay K., Elliot A., Pallant L., Sripa B., Blacksell S.D., Fenwick S., Thompson R.C. Soil-transmitted helminthiasis in Laos: a community-wide cross-sectional study of humans and dogs in a mass drug administration environment. Am. J. Trop. Med. Hyg. 2012, 86:624-634.
75. Conway D.J., Bailey J.W., Lindo J.F., Robinson R.D., Bundy D.A.P., Bianco A.E. Serum IgG reactivity with 41-, 31-, and 28-kDa larval proteins of Strongyloides stercoralis in individuals with strongyloidiasis. J. Infect. Dis. 1993, 168:784-787.
76. Copelovitch L., Sam Ol O., Taraquinio S., Chanpheaktra N. Childhood nephrotic syndrome in Cambodia: an association with gastrointestinal parasites. J.Pediatr. 2010, 156:76-81.
77. Corti M., Villafañe M.F., Trione N., Risso D., Abuín J.C., Palmieri O. Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients. Rev. Chil. Infectol. 2011, 28:217-222.
78. Costa I.N., Sopelete M.C., Gonçalves-Pires M.R.F., Costa-Cruz J.M. IgA andIgG antibodies in paired serum and saliva samples in human strongyloidiasis. Acta Parasitol. 2003, 48:306-311.
79. Costa-Cruz J.M., Bullamah C.B., Gonçalves-Pires M.R.F., Campos D.M.B., Vieira M.A. Cryo-microtome sections of coproculture larvae of Strongyloides stercoralis and Strongyloides ratti as antigen sources for the immunodiagnosis of human strongyloidiasis. Rev. Inst. Med. Trop. São Paulo 1997, 39:313-317.
80. Costa-Cruz J.M., Bullamah C.B., Gonçalves-Pires M.R.F., Campos D.M.B. Seroepidemiological study of human strongyloidiasis with blood samples collected on filter paper, in Abadia dos Dourados (Minas Gerais, Brazil). Rev. Inst. Med. Trop. São Paulo 1998, 40:329-331.
81. Costa-Cruz J.M., Madalena J., Silva D.A., Sopelete M.C., Campos D.M., Taketomi E.A. Heterologous antigen extract in ELISA for the detection of human IgE anti-Strongyloides stercoralis. Rev. Inst. Med. Trop. São Paulo 2003, 45:265-268.
82. Coster L.O. Parasitic infections in solid organ transplant recipients. Infect. Dis. Clin. North Am. 2013, 27:395-427.
83. Cremades M.J., Igual R., Ricart C., Estellés F., Pastor A., Menéndez R. Infección por Strongyloides stercoralis en la comarca de La Safor (Comunidad Valenciana). Med. Clin. (Bar.) 1997, 109:212-215.
84. Croker C., Reporter R., Redelings M., Mascola L. Strongyloidiasis-related deaths in the United States, 1991-2006. Am. J. Trop. Med. Hyg. 2010, 83:422-426.
85. Cruz R.J., Vincenzi R., Ketzer B.M. Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report. World J. Emerg. Surg. 2010, 5:23.
86. Cruz T., Reboucas G., Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N. Engl. J. Med. 1966, 275:1093-1096.
87. Cummins R.O., Suratt P.M., Horwitz D.A. Disseminated Strongyloides stercoralis infection. Association with ectopic ACTH syndrome and depressed cell-mediated immunity. Arch. Intern. Med. 1978, 138:1005-1006.
88. Dagnew M., Tiruneh M., Moges F., Tekeste Z. Survey of nasal carriage of Staphylococcus aureus and intestinal parasites among food handlers working at Gondar University, Northwest Ethiopia. BMC Public Health 2012, 12:837.
89. Dallemand S., Waxman M., Farman J. Radiological manifestations of Strongyloides stercoralis. Gastrointest. Radiol. 1983, 8:45-51.
90. Dash K., Chauhan S., Tripathy R., Chakravorty S. Strongyloides stercoralis hyperinfection with features of acute intestinal obstruction in a patient operated for prolapse disc. J. Cytol. 2012, 29:278-279.
91. Davidson R.A., Fletcher R.H., Chapman L.E. Risk factors for strongyloidiasis. Acase-control study. Arch. Intern. Med. 1984, 144:321-324.
92. Davis S., Bosserman E., Montgomery S., Woodhall D., Russell E.S. Strongyloidiasis in a rural setting-southeastern Kentucky. M. M. W. R. 2013, 62:843.
93. De Kaminsky R.G. Evaluation of three methods for laboratory diagnosis of Strongyloides stercoralis infection. J. Parasitol. 1993, 79:277-280.
94. De las Marinas M.D., Martorell A., Felix R., Cerdá J.C., García A., Navalpotro D. Strongyloidiasis: an emerging infectious disease that simulates allergic diseases. J. Investig. Allergol. Clin. Immunol. 2012, 22:286-287.
95. De Messias I.J., Genta R.M., Mohren W.D. Adherence of monocytes and polymorphonuclear cells to infective larvae of Strongyloides stercoralis after complement activation. J. Parasitol. 1994, 80:267-274.
96. De Oliveira L.C., Ribeiro C.T., Mendes D.M., Oliveira T.C., Costa-Cruz J.M. Frequency of Strongyloides stercoralis infection in alcoholics. Mem. Inst. Oswaldo Cruz 2002, 97:119-121.
97. Donadello K., Cristallini S., Taccone F.S., Lorent S., Vincent J.L., de Backer D., Jacobs F. Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature. Int. J. Antimicrob. Agents 2013, 42:580-583.
98. Dorris M., Blaxter M. The small subunit ribosomal RNA sequence of Strongyloides stercoralis. Int. J. Parasitol. 2000, 30:939-941.
99. Dorris M., Viney M.E., Blaxter M.L. Molecular phylogenetic analysis of the genus Strongyloides and related nematodes. Int. J. Parasitol. 2002, 3212:1507-1517.
100. Dreyer G., Fernandes-Silva E., Alves S., Rocha A., Albuquerque R., Addiss D. Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J. Clin. Microbiol. 1996, 34:2569-2571.
101. Dutcher J.P., Marcus S.L., Tanowitz H.B., Wittner M., Fuks J.Z., Wiernik P.H. Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma. Cancer 1990, 66:2417-2420.
102. El-Badry A.A. ELISA-based coproantigen in human strongyloidiasis: a diagnostic method correlating with worm burden. J. Egypt. Soc. Parasitol. 2009, 39:757-768.
103. El-Sameed, Y.A., Beejay, N., Al Maashari, R. Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome. Clin. Respir. J. , in press. doi:10.1111/crj.12169.
104. Fardet L., Généreau T., Cabane J., Kettaneh A. Severe strongyloidiasis in corticosteroid-treated patients. Clin. Microbiol. Infect. 2006, 12:945-947.
105. Fardet L., Généreau T., Poirot J.L., Guidet B., Kettaneh A., Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J.Infect. 2007, 54:18-27.
106. Feitosa G., Bandeira A.C., Sampaio D.P., Badaró R., Brites C. High prevalence of giardiasis and stronglyloidiasis among HIV-infected patients in Bahia, Brazil. Braz. J. Infect. Dis. 2001, 5:339-344.
107. Feliciano N.D., Gonzaga H.T., Gonçalves-Pires M.R.F., Gonçalves A.L.R., Rodrigues R.M., Ueta M.T., Costa-Cruz J.M. Hydrophobic fractions from Strongyloides venezuelensis for use in the human immunodiagnosis of strongyloidiais. Diagn. Microbiol. Infect. Dis. 2010, 67:153-161.
108. Feliciano N.D., Ribeiro S., Santos A., Fujimura P.T., Gonzaga H.T., Goulart L.R., Costa-Cruz J.M. Bacteriophage-fused peptides for serodiagnosis of human strongyloidiasis. PLoS Negl. Trop. Dis. 2014, 8:e2792.
109. Fernández-Rodríguez C., Enríquez-Matas A., Sanchéz Millán M.L., Mielgo Ballesteros R., Jukic Beteta K.D., Valdez Tejeda M., Almonte Durán P., Levano Vasquez J., Sánchez González M.J. Strongyloides stercoralis infection: a series of cases diagnosed in an allergy department in Spain. J. Investig. Allergol. Clin. Immunol. 2012, 22:455-457.
110. Friedenberg F., Wongpraparut N., Fischer R.A., Gubernick J., Zaeri N., Eiger G., Ozden Z. Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host. Dig. Dis. Sci. 1999, 44:1184-1188.
111. Gabet A.S., Mortreux,.F, Talarmin A., Plumelle Y., Leclercq I., Leroy A., Gessain A., Clity E., Joubert M., Wattel E. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000, 19:4954-4960.
112. Galioto A.M., Hess J.A., Nolan T.J., Schad G.A., Lee J.J., Abraham D. Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval Strongyloides stercoralis in mice. Infect. Immun. 2006, 74:5730-5738.
113. Genta R.M. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev. Infect. Dis. 1989, 11:755-767.
114. Genta R.M. Dysregulation of strongyloidiasis: a new hypothesis. Clin. Microbiol. Rev. 1992, 5:345-355.
115. Genta R.M., Caymmi Gomes M. Pathology. Strongyloidiasis: A Major Roundworm Infection of Man 1989, 132. Taylor & Francis, London. Grove (Ed.).
116. Genta R.M., Douce R.W., Walzer P.D. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J. Clin. Microbiol. 1986, 23:1099-1103.
117. Genta R.M., Frei D.F., Linke M.J. Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis. J. Clin. Microbiol. 1987, 25:1505-1510.
118. Ghoshal U.C., Ghoshal U., Jain M., Kumar A., Agarwal R., Misra A., Ayyagari A., Naik S.R. Strongyloides stercoralis infestation associated with septicemia dueto intestinal transmural migration of bacteria. J. Gastroenterol. Hepatol. 2002, 17:1331-1333.
119. Gill G.V., Bell D.R. Strongyloides stercoralis infection in former Far East prisoners of war. Br. Med. J. 1979, 2:572-574.
120. Gill G.V., Welch E., Bailey J.W., Bell D.R., Beeching N.J. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. Q. J. Med. 2004, 97:789-795.
121. Glinz D., Silué K.D., Knopp S., Lohourignon L.K., Yao K.P., Steinmann P., Rinaldi L., Cringoli G., N'Goran E.K., Utzinger J. Comparing diagnostic accuracy of Kato-Katz, Koga agar plate, ether-concentration, and FLOTAC for Schistosoma mansoni and soil-transmitted helminths. PLoS Negl. Trop. Dis. 2010, 4(7):e754. 10.1371/journal.pntd.0000754.
122. Gluhovschi G., Gluhovschi C., Velciov S., Ratiu I., Bozdog G., Taban S., Petrica L. 'Surprise' in the evolution of chronic membranoproliferative glomerulonephritis associated with severe strongyloidiasis under corticotherapy: 'hygienic paradox'?. Ren. Fail. 2013, 35:1017-1023.
123. Goka A.K., Rolston D.D., Mathan V.I., Farthing M.J. Diagnosis of Strongyloides and hookworm infections: comparison of faecal and duodenal fluid microscopy. Trans. R. Soc. Trop. Med. Hyg. 1990, 84:829-831.
124. Gómez-Gallego S., Loukas A., Slade R.W., Neva F.A., Varatharajalu R., Nutman T.B., Brindley P.J. Identification of an astacin-like metallo-proteinase transcript from the infective larvae of Strongyloides stercoralis. Parasitol. Int. 2005, 54:123-133.
125. Gompels M.M., Todd J., Peters B.S., Main J., Pinching A.J. Disseminated strongyloidiasis in AIDS: uncommon but important. AIDS 1991, 5:329-332.
126. Gonçalves A.L., Machado G.A., Gonçalves-Pires M.R., Ferreira-Júnior A., Silva D.A., Costa-Cruz J.M. Evaluation of strongyloidiasis in kennel dogs and keepers by parasitological and serological assays. Vet. Parasitol. 2007, 147:132-139.
127. Gonçalves A.L.R., Rocha C.A., Gonzaga H.T., Gonçalves-Pires M.R.F., Ueta M.T., Costa-Cruz J.M. Specific IgG and IgA to larvae, parthenogenetic females, and eggs of Strongyloides venezuelensis in the immunodiagnosis of human strongyloidiasis. Diagn. Microbiol. Infect. Dis. 2012, 72:79-84.
128. Gonçalves A.L.R., Nunes D.S., Gonçalves-Pires M.R.F., Ueta M.T., Costa-Cruz J.M. Use of larval, parasitic female and egg antigens from Strongyloides venezuelensis to detect parasite-specific IgG and immune complexes in immunodiagnosis of human strongyloidiasis. Parasitology 2012, 139:956-961.
129. Gonzaga H.T., Ribeiro V.S., Cunha-Junior J.P., Ueta M.T., Costa-Cruz J.M. Usefulness of concanavalin-A non-binding fraction of Strongyloides venezuelensis larvae to detect IgG and IgA in human strongyloidiasis. Diagn. Microbiol. Infect. Dis. 2011, 70:78-84.
130. Gonzaga H.T., Ribeiro V.S., Feliciano N.D., Manhani M.N., Silva D.A., Ueta M.T., Costa-Cruz J.M. IgG avidity in differential serodiagnosis of human strongyloidiasis active infection. Immunol. Lett. 2011, 139:87-92.
131. Gonzaga H.T., Vila-Verde C., Nunes D.S., Ribeiro V.S., Cunha-Junior J.P., Costa-Cruz J.M. Ion-exchange protocol to obtain antigenic fractions with potential for serodiagnosis of strongyloidiasis. Parasitology 2013, 140:69-75.
132. González A., Gallo M., Valls M.E., Muñoz J., Puyol L., Pinazo M.J., Mas J., Gascón J. Clinical and epidemiological features of 33 imported Strongyloides stercoralis infections. Trans. R. Soc. Trop. Med. Hyg. 2010, 104:613-616.
133. Gonzalez-Ibarra F., Chevli P., Schachter L., Kaur M., Eivaz-Mohammadi S., Tashtoush B., Matta J., Syed A.K., Marian V. Strongyloidiasis and diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus. Case Rep. Med. 2014, 278390.
134. Gordon S.M., Gal A.A., Solomon A.R., Bryan J.A. Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host. J. Am. Acad. Dermatol. 1994, 31:255-259.
135. Gotuzzo E., Terashima A., Alvarez H., Tello R., Infante R., Watts D.M., Freedman D.O. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am. J. Trop. Med. Hyg. 1999, 60:146-149.
136. Graeff-Teixeira C., Medeiros E., Zanini G.M., Brasil C.A., Cardozo B.L., Dalpiaz M.G., Bisol L.W. Inexpensive alternative material for the isolation of larvae with the Baermann method. Mem. Inst. Oswaldo Cruz 1997, 92:399-400.
137. Greaves D., Coggle S., Pollard C., Aliyu S.H., Moore E.M. Strongyloides stercoralis infection. BMJ 2013, 347:f4610. 10.1136/bmj.f4610.
138. Grove D.I. Strongyloidiasis in Allied ex-prisoners of war in southeast Asia. Br. Med. J. 1980, 280:598-601.
139. Grove D.I. Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Trans. R. Soc. Trop. Med. Hyg. 1982, 76:114-118.
140. Grove D.I. Human strongyloidiasis. Adv. Parasitol. 1996, 38:251-309.
141. Grove D.I., Blair A.J. Diagnosis of human strongyloidiasis by immunofluorescence, using Strongyloides ratti and S. stercoralis larvae. Am. J. Trop. Med. Hyg. 1981, 30:344-349.
142. Guidetti C., Ricci L., Vecchia L. Aetiology of intestinal parasites in a sample of students from Mozambique. Infez. Med. 2011, 19:157-165.
143. Gulbas Z., Kebapci M., Pasaoglu O., Vardareli E. Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia. South Med. J. 2004, 97:907-910.
144. Gutierrez Y., Bhatia P., Garbadawala S.T., Dobson J.R., Wallace T.M., Carey T.E. Strongyloides stercoralis eosinophilic granulomatous enterocolitis. Am. J. Surg. Pathol. 1996, 20:603-612.
145. Hamilton K.W., Abt P.L., Rosenbach M.A., Bleicher M.B., Levine M.S., Mehta J., Montgomery S.P., Hasz R.D., Bono B.R., Tetzlaff M.T., Mildiner-Early S., Introcaso C.E., Blumberg E.A. Donor-derived Strongyloides stercoralis infections in renal transplantrecipients. Transplantation 2011, 91:1019-1024.
146. Harcourt-Webster J.N., Scaravilli F., Darwish A.H. Strongyloides stercoralis hyperinfection in an HIV positive patient. J. Clin. Pathol. 1991, 4:346-348.
147. Hasegawa H., Sato H., Fujita S., Nguema P.P., Nobusue K., Miyagi K., Kooriyama T., Takenoshita Y., Noda S., Sato A., Morimoto A., Ikeda Y., Nishida T. Molecular identification of the causative agent of human strongyloidiasis acquired in Tanzania: dispersal and diversity of Strongyloides spp. and their hosts. Parasitol. Int. 2010, 59:407-413.
148. Hauber H.P., Galle J., Chiodini P.L., Rupp J., Birke R., Vollmer E., Zabel P., Lange C. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin. Infection 2005, 33:383-386.
149. Hayashi J., Kishihara Y., Yoshimura E., Furusyo N., Yamaji K., Kawakami Y., Murakami H., Kashiwagi S. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am. J. Trop. Med. Hyg. 1997, 56:71-75.
150. Herbert D.R., Lee J.J., Lee N.A., Nolan T.J., Schad G.A., Abraham D. Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J. Immunol. 2000, 165:544-551.
151. Herbert D.R., Nolan T.J., Schad G.A., Abraham D. The role of B cells in immunity against larval Strongyloides stercoralis in mice. Parasite Immunol. 2002, 24:95-101.
152. Herbert D.R., Nolan T.J., Schad G.A., Lustigman S., Abraham D. Immunoaffinity-isolated antigens induce protective immunity against larval Strongyloides stercoralis in mice. Exp. Parasitol. 2002, 100:112-120.
153. Hernández-Chavarría F., Avendaño L. A simple modification of the Baermann method for diagnosis of strongyloidiasis. Mem. Inst. Oswaldo Cruz 2001, 96:805-807.
154. Heyman B., Pilstrom L., Shulman M.J. Complement activation is required for IgM-mediated enhancement of the antibody response. J. Exp. Med. 1988, 167:1999-2004.
155. Hindy P., Parvin R., Hanna K., Gress F. Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1. Gastrointest. Endosc. 2011, 74:439-441.
156. Hirata T., Nakamura H., Kinjo N., Hokama A., Kinjo F., Yamane N., Fujita J. Increased detection rate of Strongyloides stercoralis by repeated stool examinations using the agar plate culture method. Am. J. Trop. Med. Hyg. 2007, 77:683-684.
157. Hirata T., Uchima N., Kishimoto K., Zaha O., Kinjo N., Hokama A., Sakugawa H., Kinjo F., Fujita J. Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am. J. Trop. Med. Hyg. 2006, 74:246-249.
158. Ho P.L., Luk W.K., Chan A.C., Yuen K.Y. Two cases of fatal strongyloidiasis in Hong Kong. Pathology 1997, 29:324-326.
159. Hoy W.,E., Roberts N.J., Bryson M.F., Bowles C., Lee J.C., Rivero A.J., Ritterson A.L. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA 1981, 246:1937-1939.
160. Hsieh H.C. A test-tube filter-paper method for the diagnosis of Ancylostma duodenale, Necator americanus and Strongyloides stercoralis. WHO Tech. Rep. Ser. No. 255 1963, 27-30.
161. Hu M., Chilton N.B., Gasser R.B. The mitochondrial genome of Strongyloides stercoralis (Nematoda) - idiosyncratic gene order and evolutionary implications. Int. J. Parasitol. 2003, 33:1393-1408.
162. Husni R.N., Gordon S.M., Longworth D.L., Adal K.A. Disseminated Strongyloides stercoralis infection in an immunocompetent patient. Clin. Infect. Dis. 1996, 23:663.
163. Huston J.M., Eachempati S.R., Rodney J.R., Cayci C., Fusco D., Mathew M., Shou J., Goldstein M.J., Kapur S., Barie P.S. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. Transpl. Infect. Dis. 2009, 11:277-280.
164. Ibikounlé M., Gbédjissi L.G., Ogouyèmi-Hounto A., Batcho W., Kindé-Gazard D., Massougbodji A. Schistosomiasis and soil-transmitted helminthiasis among schoolchildren of Nikki and Pèrèrè, two northeastern towns of Benin. Bull. Soc. Pathol. Exot. 2014, 107:171-176.
165. Igual-Adell R., Dominguez-Marquez V. Estrongiloidiasis: epidemiología, manifestaciones clínicas y diagnóstico. Experiencia en una zona endémica: la comarca de La Safor (Valencia). Enferm. Infecc. Microbiol. Clin. 2007, 25:38-44.
166. Igual-Adell R., Oltra-Alcaraz C., Soler-Company E., Sánchez-Sánchez P., Matogo-Oyana J., Rodríguez-Calabuig D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin. Pharmacother. 2004, 5:2615-2619.
167. Ines E.J., Souza J.N., Santos R.C., Souza E.S., Santos F.L., Silva M.L.S., Silva M.P., Teixeira M.C.A., Soares N.M. Efficacy of parasitological methods for the diagnosis of Strongyloides stercoralis and hookworm in faecal specimens. Acta Trop. 2011, 120:206-210.
168. Inês E.J., Silva M.L., Souza J.N., Teixeira M.C., Soares N.M. The role of glycosylated epitopes in the serodiagnosis of Strongyloides stercoralis infection. Diagn. Microbiol. Infect. Dis. 2013, 76:31-35.
169. Intapan P.M., Maleewong W., Wongsaroj T., Singthong S., Morakote N. Comparison of the quantitative formalin ethyl acetate concentration technique and agar plate culture for diagnosis of human strongyloidiasis. J. Clin. Microbiol. 2005, 43:1932-1933.
170. Iriemenam N.C., Sanyaolu A.O., Oyibo W.A., Fagbenro-Beyioku A.F. Strongyloides stercoralis and the immune response. Parasitol. Int. 2010, 59:9-14.
171. Izquierdo I., Briones J., Lluch R., Arqueros C., Martino R. Fatal strongyloides hyperinfection complicating a gram-negative sepsis after allogeneic stem cell transplantation: a case report and review of the literature. Case Rep. Hematol. 2013, 2013. ID 860976.
172. Jain A.K., Agarwal S.K., el-Sadr W. Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus. Clin. Infect. Dis. 1994, 18:253-254.
173. Jaka H., Koy M., Egan J.P., Meda J.R., Mirambo M., Mazigo H.D., Kabangila R., Wang Y.L., Mueller A., Peck R.N., Mchembe M.D., Chalya P.L. Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report. Trop. Doct. 2013, 43:46-48.
174. Jamil S.A., Hilton E. The Strongyloides hyperinfection syndrome. N. Y. State J. Med. 1992, 92:67-68.
175. Janssen S., Rossatanga E.G., Jurriaans S., Ten Berge I.J., Grobusch M.P. Triple infection with HIV-1, HTLV-1 and Strongyloides stercoralis, rendering CD4+ T-cell counts a misleading entity. Antivir. Ther. 2013, 18:949-951.
176. Janwan P., Intapan P.M., Thanchomnang T., Lulitanond V., Anamnart W., Maleewong W. Rapid detection of Opisthorchis viverrini and Strongyloides stercoralis in human fecal samples using a duplex real-time PCR and melting curve analysis. Parasitol. Res. 2011, 109:1593-1601.
177. Jongwutiwes S., Charoenkorn M., Sitthichareonchai P., Akaraborvorn P., Putaporntip C. Increased sensitivity of routine laboratory detection of Strongyloides stercoralis and hookworm by agar-plate culture. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:398-400.
178. Jongwutiwes U., Waywa D., Silpasakorn S., Wanachiwanawin D., Suputtamongkol Y. Prevalence and risk factors of acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in Thailand. Pathog. Glob. Health 2014, 108:137-140.
179. Jorgensen T., Montresor A., Savioli L. Effectively controlling strongyloidiasis. Parasitol. Today 1996, 12:164.
180. Kaewpitoon S.J., Rujirakul R., Ueng-Arporn N., Matrakool L., Namwichaisiriku N., Churproong S., Wongkaewpothong P., Nimkuntod P., Sripa B., Kaewpitoon N. Community-based cross-sectional study of carcinogenic human liver fluke in elderly from Surin province, Thailand. Asian Pac. J. Cancer Prev. 2012, 13:4285-4288.
181. Kalita J., Bhoi S.K., Misra U.K. Fatal Strongyloides stercoralis infection in a patient withchronic inflammatory demyelinating polyneuropathy. Pathog. Glob. Health 2012, 106:249-251.
182. Kapila K., Pathan S.K., Al-Boloushi K. Diagnosis of Strongyloides stercoralis in a routine cervical smear. Diagn. Cytopathol. 2005, 33:31-32.
183. Keiser P.B., Nutman T.B. Strongyloides stercoralis in the immunocompromised population. Clin. Microbiol. Rev. 2004, 17:208-217.
184. Kennedy S., Campbell R.M., Lawrence J.E., Nichol G.M., Rao D.M. A case of severe Strongyloides stercoralis infection with jejunal perforation in an Australian ex-prisoner-of-war. Med. J. Aust. 1989, 150:92-93.
185. Kerepesi L.A., Hess J.A., Leon O., Nolan T.J., Schad G.A., Abraham D. Toll-like receptor 4 (TLR4) is required for protective immunity to larval Strongyloides stercoralis in mice. Microbes Infect. 2007, 9:28-34.
186. Kerepesi L.A., Hess J.A., Nolan T.J., Schad G.A., Abraham D. Complement component C3 is required for protective innate and adaptive immunity to larval Strongyloides stercoralis in mice. J. Immunol. 2006, 176:4315-4322.
187. Kerepesi L.A., Keiser P.B., Nolan T.J., Schad G.A., Abraham D., Nutman T.B. DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice. Infect. Immun. 2005, 73:2298-2305.
188. Kerepesi L.A., Nolan T.J., Schad G.A., Lustigman S., Herbert D.R., Keiser P.B., Nutman T.B., Krolewiecki A.J., Abraham D. Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice. J. Infect. Dis. 2004, 189:1282-1290.
189. Khan W.A., Santhanakrishnan K. Hypereosinophilic syndrome secondary to strongyloides infection: a case of recurrent asthma exacerbations. BMJ Case Rep. 2013, 1-3. 10.1136/bcr-2013-009587.
190. Khasawneh F., Sreedhar R., Chundi V. Strongyloides hyperinfection: an unusual cause of respiratory failure. Ann. Intern. Med. 2009, 150:570-571.
191. Khieu V., Schär F., Forrer A., Hattendorf J., Marti H., Duong S., Vounatsou P., Muth S., Odermatt P. High prevalence and spatial distribution of Strongyloides stercoralis in rural Cambodia. PLoS Negl. Trop. Dis. 2014, 8:e2854.
192. Khieu V., Schär F., Marti H., Bless P.J., Char M.C., Muth S., Odermatt P. Prevalence and risk factors of Strongyloides stercoralis in Takeo Province, Cambodia. Parasite Vectors 2014, 7:221.
193. Khieu V., Schär F., Marti H., Sayasone S., Duong S., Muth S., Odermatt P. Diagnosis, treatment and risk factors of Strongyloides stercoralis in schoolchildren in Cambodia. PLoS Negl. Trop. Dis. 2013, 7(2):e2035. 10.1371/journal.pntd.0002035.
194. Khuroo M.S. Hyperinfection strongyloidiasis in renal transplant recipients. BMJ Case Rep 2014, 10.1136/bcr-2014-205068.
195. Kishimoto K., Hokama A., Hirata T., Ihama Y., Nakamoto M., Kinjo N., Kinjo F., Fujita J. Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. World J. Gastroenterol. 2008, 14:1768-1773.
196. King S., Mascie-Taylor C.G.C. Strongyloides fuelleborni kellyi and other intestinal helminthes in children from Papua New Guinea: associations with nutritional status and socioeconomic factors. P. N. G. Med. J. 2004, 47:181-191.
197. Knight W.B., Hiatt R.A., Cline B.L., Ritchie L.S. A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1976, 55:818-823.
198. Knopp S., Mohammed K.A., Simba Khamis I., Mgeni A.F., Stothard J.R., Rollinson D., Marti H., Utzinger J. Spatial distribution of soil-transmitted helminths, including Strongyloides stercoralis, among children in Zanzibar. Geospat. Health 2008, 3:47-56.
199. Knopp S., Mgeni A.F., Khamis I.S., Steinmann P., Stothard J.R., Rollinson D., Marti H., Utzinger J. Diagnosis of soil-transmitted helminths in the era of preventive chemotherapy: effect of multiple stool sampling and use of different diagnostic techniques. PLoS Negl. Trop. Dis. 2008, 2(11):e331. 10.1371/journal.pntd.0000331.
200. Knopp S., Salim N., Schindler T., Karagiannis Voules D.A., Rothen J., Lweno O., Mohammed A.S., Singo R., Benninghoff M., Nsojo A.A., Genton B., Daubenberger C. Diagnostic accuracy of Kato-Katz, FLOTAC, Baermann, and PCR methods for the detection of light-intensity hookworm and Strongyloides stercoralis infections in Tanzania. Am. J. Trop. Med. Hyg. 2014, 90:535-545.
201. Knopp S., Stothard J.R., Rollinson D., Mohammed K.A., Khamis I.S., Marti H., Utzinger J. From morbidity control to transmission control: time to change tactics against helminths on Unguja Island, Zanzibar. Acta Trop. 2013, 128:412-422.
202. Koga K., Kasuya S., Khamboonruang C., Sukhavat K., Ieda M., Takatsuka N., Kita K., Ohtomo H. A modified agar plate method for detection of Strongyloides stercoralis. Am. J. Trop. Med. Hyg. 1991, 45:518-521.
203. Kothary N.N., Muskie J.M., Mathur S.C. Strongyloides stercoralis hyperinfection. Radiographics 1999, 19:1077-1081.
204. Kramer M.R., Gregg P.A., Goldstein M., Llamas R., Krieger B.P. Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: diagnosis by sputum and bronchoalveolar lavage. South Med. J. 1990, 83:1226-1229.
205. Kramme F., Nissen N., Soblik H., Erttmann K., Tannich E., Fleischer B., Panning M., Bratting N. Novel real-time PCR for the universal detection of Strongyloides species. J. Med. Microbiol. 2011, 60:454-458.
206. Kratimenos P., Koutroulis I., Vasireddy D., Degroote R., Fisher M.C. Strongyloidiasis in a healthy 8-year-old girl in north-eastern USA. Paediatr. Int. Child. Health 2015, 35:72-74.
207. Krishnamurthy R., Dincer H.E., Whittemore D. Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. J. Clin. Rheumatol. 2007, 13:150-152.
208. Krolewiecki A.J., Lammie P., Jacobson J., Gabrielli A.F., Levecke B., Socias E., Arias L.M., Sosa N., Abraham D., Cimino R., Echazú A., Crudo F., Vercruysse J., Albonico M. A public health response against Strongyloides stercoralis: time to look at soil-transmitted helminthiasis in full. PLoS Negl. Trop. Dis. 2013, 7:e2165.
209. Krolewiecki A.J., Ramanathan R., Fink V., Mcauliffe I., Cajal S.P., Won K., Juarez M., Di Paolo A., Tapia L., Acosta N., Lee R., Lammie P., Abraham D., Nutman T. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in Northern Argentina. Clin. Vaccine Immunol. 2010, 10:1624-1630.
210. Kuzucu A. Parasitic diseases of the respiratory tract. Curr. Opin. Pulm. Med. 2006, 12:212-221.
211. Lai C.P., Hsu Y.H., Wang J.H., Lin C.M. Strongyloides stercoralis infection with bloody pericardial effusion in a non-immunosuppressed patient. Circ. J. 2002, 66:613-614.
212. Lam C.S., Tong M.K., Chan K.M., Siu Y.P. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:14-18.
213. Lamps L.W. Infectious causes of appendicitis. Infect. Dis. Clin. North Am. 2010, 24:995-1018.
214. Leapman S.B., Rosenberg J.B., Filo R.S., Smith E.J. Strongyloides stercoralis in chronic renal failure: safe therapy with thiabendazole. South Med. J. 1980, 73:1400-1402.
215. Leighton P.M., MacSween H.M. Strongyloides stercoralis. The cause of an urticarial-like eruption of 65years' duration. Arch. Intern. Med. 1990, 150:1747-1748.
216. Lessnau K.D., Can S., Talavera W. Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature. Chest 1993, 104:119-122.
217. Levenhagen M.A., Costa-Cruz J.M. Update on immunologic and molecular diagnosis of human strongyloidiasis. Acta Trop. 2014, 135:33-43.
218. Levi G.C., Kallás E.G., Ramos Moreira Leite K. Disseminated Strongyloides stercoralisinfection in an AIDS patient: the role of suppressive therapy. Braz. J. Infect. Dis. 1997, 1:48-51.
219. Levi M.E., Kumar D., Green M., Ison M.G., Kaul D., Michaels M.G., Morris M.I., Schwartz B.S., Echenique I.A., Blumberg E.A. AST ID Community of Practice. Considerations for screening live kidney donors for endemic infections: a viewpoint on the UNOS policy. Am. J. Transpl. 2014, 14:1003-1011.
220. Liepman M. Disseminated Strongyloides stercoralis. A complication of immunosuppression. JAMA 1975, 231:387-388.
221. Ligas J.A., Kerepesi L.A., Galioto A.M., Lustigman S., Nolan T.J., Schad G.A., Abraham D. Specificity and mechanism of immunoglobulin M (IgM)- and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice. Infect. Immun. 2003, 71:6835-6843.
222. Lindo J.F., Conway D.J., Atkins N.S., Bianco A.E., Robinson R.D., Bundy D.A.P. Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection. Am. J. Trop. Med. Hyg. 1994, 51:175-179.
223. Link K., Orenstein R. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med. J. 1999, 92:728-731.
224. Little M.D. Comparative morphology of si species of Strongyloides (Nematoda) and redefinition of the genus. J. Parasitol. 1966, 72:372-382.
225. Llagunes J., Mateo E., Peña J.J., Carmona P., de Andrés J. Hyperinfection caused by Strongyloides stercoralis. Med. Intensiva 2010, 34:353-356.
226. Maayan S., Wormser G.P., Widerhorn J., Sy E.R., Kim Y.H., Ernst J.A. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am. J. Med. 1987, 83:945-948.
227. Machado E.R., Faccioli L.H., Costa-Cruz J.M., Lourenço E.V., Roque-Barreira M.C., Gonçalves-Pires M.R.F., Ueta M.T. Strongyloides venezuelensis: the antigenic identity of eight strains for the immunodiagnosis of human strongyloidiasis. Exp. Parasitol. 2008, 119:7-14.
228. Machado E.R., Ueta M.T., Gonçalves-Pires M.R.F., Alves de Oliveira J.B., Faccioli L.H., Costa-Cruz J.M. Strongyloides venezuelensis alkaline extract for the diagnosis of human strongyloidiasis by enzyme-linked immunosorbent assay. Mem. Inst. Oswaldo Cruz 2003, 98:849-851.
229. Machado E.R., Ueta M.T., Gonçalves-Pires M.R.F., Oliveira J.B.A., Faccioli L.H., Costa-Cruz J.M. Diagnosis of humam strongyloidiasis using particulate antigen of two strains of Strongyloides venezuelensis in indirect immunofluorescence antibody test. Exp. Parasitol. 2001, 99:52-55.
230. Machicado J.D., Marcos L.A., Tello R., Canales M., Terashima A., Gotuzzo E. Diagnosis of soil-transmitted helminthiasis in an Amazonic community of Peru using multiple diagnostic techniques. Trans. R. Soc. Trop. Med. Hyg. 2012, 106:333-339.
231. Mamo H. Intestinal parasitic infections among prison inmates and tobacco farm workers in Shewa Robit, North-Central Ethiopia. PLoS One 2014, 9:e99559.
232. Mangali A., Chaicumpa W., Nontasut P., Chantavanij P., Tapchaisri P., Viravan C. Enzyme-linked immunosorbent assay for diagnosis of human strongyloidiasis. Southeast Asian J. Trop. Med. Public Health 1991, 22:88-92.
233. Manganelli L., Berrilli F., Di Cave D., Ercoli L., Capelli G., Otranto D., Giangaspero A. Intestinal parasite infections in immigrant children in the city of Rome, related risk factors and possible impact on nutritional status. Parasite Vectors 2012, 5:265.
234. Mansfield L.S., Niamatali S., Bhopale V., Volk S., Smith G., Lok J.B., Genta R.M., Schad G.A. Strongyloides stercoralis: maintenance of exceedingly chronic infections. Am. J. Trop. Med. Hyg. 1996, 55:617-624.
235. Marathe A., Date V. Strongyloides stercoralis hyperinfection in an immunocompetent patient with extreme eosinophilia. J. Parasitol. 2008, 94:759-760.
236. Marcilla A., Garg G., Bernal D., Ranganathan S., Forment J., Ortiz J., Muñoz-Antolí C., Dominguez M.V., Pedrola L., Martinez-Blanch J., Sotillo J., Trelis M., Toledo R., Esteban J.G. The transcriptome analysis of Strongyloides stercoralis L3i larvae reveals targets for intervention in a neglected disease. PLoS Negl. Trop. Dis. 2012, 6:e1513.
237. Marcilla A., Sotillo J., Pérez-Garcia A., Igual-Adell R., Valero M.L., Sánchez-Pino M.M., Bernal D., Muñoz-Antolí C., Trelis M., Toledo R., Esteban J.G. Proteomic analysis of Strongyloides stercoralis L3 larvae. Parasitology 2010, 137:1577-1583.
238. Marcos L.A., Terashima A., Canales M., Gotuzzo E. Update on strongyloidiasis in the immunocompromised host. Curr. Infect. Dis. Rep. 2011, 13:35-46.
239. Marcos L.A., Terashima A., Dupont H.L., Gotuzzo E. Strongyloides hyper-infection syndrome: an emerging global infectious disease. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:314-318.
240. Marti H., Haji H.J., Savioli L., Chwaya H.M., Mgeni A.F., Ameir J.S., Hatz C. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg. 1996, 55:477-481.
241. Martin S.J., Cohen P.R., MacFarlane D.F., Grossman M.E. Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient. Skinmed 2011, 9:199-202.
242. Martín-Rabadán P., Muñoz P., Palomo J., Bouza E. Strongyloidiasis: the Harada-Mori test revisited. Clin. Microbiol. Infect. 1999, 5:374-376.
243. Marty F.M., Lowry C.M., Rodriguez M., Milner D.A., Pieciak W.S., Sinha A., Fleckenstein L., Baden L.R. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin. Infect. Dis. 2005, 41(1):e5-8.
244. McNeely D.J., Inouye T., Tam P.Y., Ripley S.D. Acute respiratory failure due to strongyloidiasis in polymyositis. J. Rheumatol. 1980, 7:745-750.
245. McRury J., De Messias I.T., Walzer P.D., Huitger T., Genta R.M. Specific IgE responses in human strongyloidiasis. Clin. Exp. Immunol. 1986, 65:631-638.
246. Medina L.S., Heiken J.P., Gold R.P. Pipestem appearance of small bowel in strongyloidiasis is not pathognomonic of fibrosis and irreversibility. AJR Am. J. Roentgenol. 1992, 159:543-544.
247. Meine G.C., Dietz J., Rocha M., Mattos T., de Souza A.R., Conteletti F.R. Atypical gastric presentation of strongyloidiasis in HIV-infected patient-case report. Dig. Liver Dis. 2004, 36:760-762.
248. Mejia R., Nutman T.B. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr. Opin. Infect. Dis. 2012, 25:458-463.
249. Mestecky J., Russell M.W. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol. Lett. 2009, 124:57-62.
250. Meyers W.M., Neafie R.C., Marty A.M. Strongyloidiasis. Pathology of Infectious Diseases. Volume I. Helmintiases 2000, 341-352. Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC. Meyers, Neafie, Marty, Wear (Eds.).
251. Milder J.E., Walzer P.D., Kilgore G., Rutherford I., Klein M. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 1981, 80:1481-1488.
252. Miller M.A., Church L.W., Salgado C.D. Strongyloides hyperinfection: a treatment dilemma. Am. J. Med. Sci. 2008, 336:358-361.
253. Minematsu H., Hokama A., Makishi T., Arakaki K., Kinjo F., Fujita J. Colonoscopic findings and pathologic characteristics of Strongyloides colitis: a case series. Digestion 2011, 83:210-214.
254. Mir A., Benahmed D., Igual R., Borrás R., O'Connor J.E., Moreno M.J., Rull S. Eosinophil-selective mediators in human strongyloidiasis. Parasite Immunol. 2006, 28:397-400.
255. Mirdha B.R. Human strongyloidiasis: often brushed under the carpet. Trop. Gastroenterol. 2009, 30:1-4.
256. Mitreva M., McCarter J.P., Martin J., Dante M., Wylie T., Chiapelli B., Pape D., Clifton S.W., Nutman T.B., Waterston R.H. Comparative genomics of gene expression in the parasitic and free-living nematodes Strongyloides stercoralis and Caenorhabditis elegans. Genome Res. 2004, 14:209-220.
257. Mittal S., Sagi S.V., Hawari R. Strongyloidiasis: endoscopic diagnosis. Clin. Gastroenterol. Hepatol. 2009, 7(2):e8. 10.1016/j.cgh.2008.08.045.
258. Moghaddassani H., Mirhendi H., Hosseini M., Rokni M., Mowlavi G.H., Kia E.B. Molecular diagnosis of Strongyloides stercoralis infection by PCR detection of specific DNA in human stool samples. Iran. J. Parasitol. 2011, 6:23-30.
259. Mohammad K.A., Koshak E.A. A prospective study on parasites among expatriateworkers in Al-Baha from 2009-2011, Saudi Arabia. J. Egypt. Soc. Parasitol. 2011, 41:423-432.
260. Mohanasundaram K., Rajasekaran K., Selvaraj J., Balasubramanian A. Successful treatment of Strongyloides stercoralis hyperinfection in a case of systemic lupus erythematosus - review of the literature regarding various treatment schedules. Trop. Doct. 2012, 42:223-225.
261. Mokaddas E.M., Shati S., Abdulla A., Nampoori N.R., Iqbal J., Nair P.M., Said T., Abdulhalim M., Hira P.R. Fatal strongyloidiasis in three kidney recipients in Kuwait. Med. Princ. Pract. 2009, 18:414-417.
262. Montes M., Sawhney C., Barros N. Strongyloides stercoralis: there but not seen. Curr. Opin. Infect. Dis. 2010, 23:500-504.
263. Moore C.E., Hor P.C., Soeng S., Sun S., Lee S.J., Parry C.M., Day N.P., Stoesser N. Changing patterns of gastrointestinal parasite infections in Cambodian children: 2006-2011. J. Trop. Pediatr. 2012, 58:509-512.
264. Moore T.A., Ramachandran S., Gam A.A., Neva F.A., Lu W., Saunders L., Williams S.A., Nutman T.B. Identification of novel sequences and codon usage in Strongyloides stercoralis. Mol. Biochem. Parasitol. 1996, 79:243-248.
265. Mora C.S., Segami M.I., Hidalgo J.A. Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome. Semin. Arthritis Rheum. 2006, 36:135-143.
266. Mota-Ferreira D.M.L., Gonçalves-Pires M.R.F., Ferreira-Junior A., Sopelete M.C., Abdallah V.O.S., Costa-Cruz J.M. Specific IgA and IgG antibodies in paired serum and breast milk samples in human strongyloidiasis. Acta Trop. 2009, 109:103-107.
267. Muennig P., Pallin D., Challah C., Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol. Infect. 2004, 132:1055-1063.
268. Mühlhauser M., Rivas L.M. Strongyloides stercoralis. Rev. Chil. Infectol. 2013, 30:513-514.
269. Nagayasu E., Ogura Y., Itoh T., Yoshida A., Chakraborty G., Hayashi T., Maruyama H. Transcriptomic analysis of four developmental stages of Strongyloides venezuelensis. Parasitol. Int. 2013, 62:57-65.
270. Najmuddin A., Hadique S., Parker J. Strongyloides hyperinfection syndrome complications: a case report and review of the literature. W. V. Med. J. 2012, 108:32-38.
271. Nakada K., Kohakura M., Komoda H., Hinuma Y. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1984, 1:633.
272. Nandy A., Addy M., Patra P., Bandyopashyay A.K. Fulminating strongyloidiasis complicating Indian kala-azar. Trop. Geogr. Med. 1995, 47:139-141.
273. Naquira C., Jimenez G., Guerra J.G., Bernal R., Nalin D.R., Neu D., Aziz M. Ivermectin for human strongyloidiasis and other intestinal helminths. Am. J. Trop. Med. Hyg. 1989, 40:304-309.
274. Naves M.M., Costa-Cruz J.M. High prevalence of Strongyloides stercoralis infection among the elderly in Brazil. Rev. Inst. Med. Trop. São Paulo 2013, 55:309-313.
275. Neefe L.I., Pinilla O., Garagusi V.F., Bauer H. Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy. Am. J. Med. 1973, 55:832-838.
276. Neimeister R., Logan A.L., Gerber B., Egleton J.H., Kleger B. Hemo-De as substitute for ethyl acetate in formalin-ethyl acetate concentration technique. J. Clin. Microbiol. 1987, 25:425-426.
277. Nesheli H.M., Moghaddam T.G., Zahedpasha Y., Norouzi A.R. Acute lymphoblastic leukemia with eosinophilia and Strongyloides stercoralis hyperinfection. Iran. J. Pediatr. 2011, 21:549-552.
278. Neva F.A., Filho J.O., Gam A.A., Thompson R., Freitas V., Melo A., Carvalho E.M. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J.Infect. Dis. 1998, 178:1856-1859.
279. Neva F.A., Gam A.A., Burke J. Comparison of larval antigens in an enzyme-linked immunosorbent assay for strongyloidiasis in humans. J. Infect. Dis. 1981, 144:427-432.
280. Newton R.C., Limpuangthip P., Greenberg S., Gam A., Neva F.A. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am. J. Med. 1992, 92:202-208.
281. Nilforoushan M.R., Mirhend H., Rezaie S., Rezaian M., Meamar A.R., Kia E.B.A. DNA-based identification of Strongyloides stercoralis isolates from Iran. Iran. J. Public Health 2007, 36:16-20.
282. Nkenfou C.N., Nana C.T., Payne V.K. Intestinal parasitic infections in HIV infected and non-infected patients in a low HIV prevalence region, West-Cameroon. PLoS One 2013, 8:e57914.
283. Nomura J., Rekrut K. Strongyloides stercoralis hyperinfection syndrome in a patient with AIDS: diagnosis by fluorescent microscopy. Clin. Infect. Dis. 1996, 22:736.
284. Nonaka D., Takaki K., Tanaka M., Umeno M., Takeda T., Yoshida M., Haraguch Y., Okada K., Sawae Y. Paralytic ileus due to strongyloidiasis: case report and review of the literature. Am. J. Trop. Med. Hyg. 1998, 59:535-538.
285. Nontasut P., Muennoo C., Sa-nguankiat S., Fongsri S., Vichit A. Prevalence of Strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian J. Trop. Med. Public Health 2005, 36:442-444.
286. Norsyahida A., Riazi M., Sadjjadi S.M., Muhammad Hafiznur Y., Low H.C., Zeehaida M., Noordin R. Laboratory detection of strongyloidiasis: IgG-, IgG4- and IgE-ELISAs and cross-reactivity with lymphatic filariasis. Parasite Immunol. 2013, 35:174-179.
287. Northern C., Grove D.I. Antigenic analysis of Strongyloides ratti infectivelarvae and adult worms. Immunol. Cell. Biol. 1987, 65:231-239.
288. Northern C., Grove D.I. Strongyloides stercoralis: antigenic analysis of infective larvae and adult worms. Int. J. Parasitol. 1990, 20:381-387.
289. Nucci M., Portugal R., Pulcheri W., Spector N., Ferreira S.B., de Castro M.B., Noe R., de Oliveira H.P. Strongyloidiasis in patients with hematologic malignancies. Clin. Infect. Dis. 1995, 21:675-677.
290. O'Connell A.E., Redding K.M., Hess J.A., Lok J.B., Nolan T.J., Abraham D. Soluble extract from the nematode Strongyloides stercoralis induces CXCR2 dependent/IL-17 independent neutrophil recruitment. Microbes Infect. 2011, 13:536-544.
291. O'Connell A.E., Hess J.A., Santiago G.A., Nolan T.J., Lok J.B., Lee J.J., Abraham D. Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice. Infect. Immun. 2011, 79:2770-2778.
292. O'Doherty M.J., Van de Pette J.E., Nunan T.O., Croft D.N. Recurrent Strongyloides stercoralis infection in a patient with T-cell lymphoma-leukaemia. Lancet 1984, 1:858.
293. Olsen A., van Lieshout L., Marti H., Polderman T., Polman K., Steinmann P., Stothard R., Thybo S., Verweij J.J., Magnussen P. Strongyloidiasis-the most neglected of the neglected tropical diseases?. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:967-972.
294. Orihel T.C., Ash L.R. Parasites in Human Tissues 1995, American Society of Clinical Pathologists, Chicago.
295. Paboriboune P., Phoumindr N., Borel E., Sourinphoumy K., Phaxayaseng S., Luangkhot E., Sengphilom B., Vansilalom Y., Odermatt P., Delaporte E., Etard J.F., Rabodonirina M. Intestinal parasitic infections in HIV-infected patients, Lao People's Democratic Republic. PLoS One 2014, 9:e91452.
296. Pacanowski J., Santos M.D., Roux A., LE Maignan C., Guillot J., Lavarde V., Cornet M. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am. J. Trop. Med. Hyg. 2005, 73:122-124.
297. Padigel U.M., Lee J.J., Nolan T.J., Schad G.A., Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect. Immun. 2006, 74:3232-3238.
298. Padigel U.M., Stein L., Redding K., Lee J.J., Nolan T.J., Schad G.A., Birnbaumer L., Abraham D. Signaling through Galphai2 protein is required for recruitment of neutrophils for antibody-mediated elimination of larval Strongyloides stercoralis in mice. J. Leukoc. Biol. 2007, 81:1120-1126.
299. Page W.A., Dempsey K., McCarthy J.S. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:1056-1062.
300. Pak B.J., Vasquez-Camargo F., Kalinichenko E., Chiodini P.L., Nutman T.B., Tanowitz H.B., McAuliffe I., Wilkins P., Smith P.T., Ward B.J., Libman M.D., Ndao M. Development of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based biosensor technology. PLoS Negl. Trop. Dis. 2014, 8:e3002.
301. de Paola D., Dias L.B., da Silva J. Enteritis due to Strongyloides stercoralis. A report of 5 fatal cases. Am. J. Dig. Dis. 1962, 7:1086-1098.
302. Paula F.M., Costa-Cruz J.M. Epidemiological aspects of strongyloidiasis in Brazil. Parasitology 2011, 138:1331-1340.
303. Perez P., Debourgogne A., Valloton T., Nani A., Barraud H., Machouart M. High risk of strongyloïdes hyperinfection in a patient with sarcoidosis. Ann. Biol. Clin-Paris 2013, 71:211-214.
304. Phelps K.R. Strongyloides hyperinfection in patients coinfected with HTLV-I and S.stercoralis. Am. J. Med. 1993, 94:447-449.
305. Pichard D.C., Hensley J.R., Williams E., Apolo A.B., Klion A.D., DiGiovanna J.J. Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppression. J. Am. Acad. Dermatol. 2014, 70:1130-1134.
306. Plumelle Y., Gonin C., Edouard A., Bucher B.J., Thomas L., Brebion A., Panelatti G. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am. J. Clin. Pathol. 1997, 107:81-87.
307. Pornsuriyasak P., Niticharoenpong K., Sakapibunnan A. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. Southeast Asian J. Trop. Med. Public Health 2004, 35:531-534.
308. Porto A.F., Neva F.A., Bittencourt H., Lisboa W., Thompson R., Alcantara L., Carvalho E.M. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol. 2001, 23:503-507.
309. Prendki V., Fenaux P., Durand R., Thellier M., Bouchaud O. Strongyloidiasis in man 75years after initial exposure. Emerg. Infect. Dis. 2011, 17:931-932.
310. Puthiyakunnon S., Boddu S., Li Y., Zhou X., Wang C., Li J., Chen X. Strongyloidiais - an insight into its global prevalence and management. PLos Negl. Trop. D. 2014, 8:e3018.
311. Putland R.A., Thomas S.M., Grove D.I., Johnson A.M. Analysis of the 18S ribosomal RNA gene of Strongyloides stercoralis. Int. J. Parasitol. 1993, 23:149-151.
312. Rajapurkar M., Hegde U., Rokhade M., Gang S., Gohel K. Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure. Nat. Clin. Pract. Nephrol. 2007, 3:573-577.
313. Ramachandran S., Gam A.A., Neva F.A. Molecular differences between several species of Strongyloides and comparison of selected isolates of S. stercoralis using a polymerase chain reaction-linked restriction fragment length polymorphism approach. Am. J. Trop. Med. Hyg. 1997, 56:61-65.
314. Ramachandran S., Thompson R.W., Gam A.A., Neva F.A. Recombinant cDNA clones for immunodiagnosis of strongyloidiasis. J. Infect. Dis. 1998, 177:196-203.
315. Ramanathan R., Burbelo P.D., Groot S., Iadarola M.J., Neva F.A., Nutman T.B. A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J. Infect. Dis. 2008, 198:444-451.
316. Ramanathan R., Nutman T. Strongyloides stercoralis infection in the immunocompromised host. Curr. Infect. Dis. Rep. 2008, 10:105-110.
317. Ramanathan R., Varma S., Ribeiro J.M., Myers T.G., Nolan T.J., Abraham D., Lok J.B., Nutman T.B. Microarray-based analysis of differential gene expression between infective and noninfective larvae of Strongyloides stercoralis. PLoS Negl. Trop. Dis. 2011, 5:e1039.
318. Ramírez-Olivencia G., Espinosa M.A., Martín A.B., Núñez N.I., de Las Parras E.R., Núñez M.L., Puente S.P. Imported strongyloidiasis in Spain. Int. J. Infect. Dis. 2014, 18:32-37.
319. Ratner L., Grant C., Zimmerman B., Fritz J., Weil G., Denes A., Suresh R., Campbell N., Jacobson S., Lairmore M. Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia. Am. J. Hematol. 2007, 82:929-931.
320. Ravi V., Ramachandran S., Thompson R.W., Andersen J.F., Neva F.A. Characterization of a recombinant immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae. Mol. Biochem. Parasitol. 2002, 125:73-81.
321. Reddy I.S., Swarnalata G. Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: report of two cases. Indian J. dermatol. Venereol. Leprol. 2005, 71:38-40.
322. Reddy T.S., Myers J.W. Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection. Am. J. Med. Sci. 2003, 325:288-291.
323. Repetto S.A., Alba-Soto C.D.A., Cazorla S.I., Tayeldin M.L., Cuello S., Lasala M.B., Tekiel V.S., González-Cappa S.M. An improved DNA isolation techniquefor PCR detection of Strongyloides stercoralis in stool samples. Acta Trop. 2013, 126:110-114.
324. Repetto S.A., Durán P.A., Lasala M.B., González-Cappa S.M. High rate of strongyloidosis infection, out of endemic area, in patients with eosinophilia and without risk of exogenous reinfections. Am. J. Trop. Med. Hyg. 2010, 82:1088-1093.
325. Requena-Méndez A., Chiodini P., Bisoffi Z., Buonfrate D., Gotuzzo E., Muñoz J. The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl. Trop. Dis. 2013, 7:e2002. 10.1371/journal.pntd.0002002.
326. Ribeiro V.S., Feliciano N.D., Gonzaga H.T., Costa I.N., Gonçalves-Pires M.R.F., Ueta M.T., Costa-Cruz J.M. Detergent fraction of heterologous antigen to detect IgA and IgG in strongyloidiasis using saliva and serum paired samples. Immunol. Lett. 2010, 134:69-74.
327. Richter J., Müller-Stöver I., Strothmeyer H., Göbels K., Schmitt M., Häussinger D. Arthritis associated with Strongyloides stercoralis infection in HLA B-27-positive African. Parasitol. Res. 2006, 99:706-707.
328. Rigo C.R., Lescano S.Z., Marchi C.R., Amato Neto V. Avaluação da resposta imune humoral frente a antígenos de Strongyloides venezuelensis. Rev. Soc. Bras. Med. Trop. 2008, 41:648-653.
329. Ritchie L.S. An ether sedimentation technique for routine stool examinations. Bull. US Army Med. Dept. 1948, 8:326.
330. Rivasi F., Pampiglione S., Boldorini R., Cardinale L. Histopathology of gastric and duodenal Strongyloides stercoralis locations in fifteen immunocompromised subjects. Arch. Pathol. Lab. Med. 2006, 130:1792-1798.
331. Rivera E., Maldonado N., Vélez-García E., Grillo A.J., Malaret G. Hyperinfection syndrome with Strongyloides stercoralis. Ann. Intern. Med. 1970, 72:199-204.
332. Rivero-Rodríguez Z., Hernández A., Bracho Á., Salazar S., Villalobos R. Prevalence of intestinal microsporidia and other intestinal parasites in hiv positive patients from Maracaibo, Venezuela. Biomedica 2013, 33:538-545.
333. Rodrigues M.A., Fróes R.C., Anefalos A., Kobayasi S. Invasive enteritis by Strongyloides stercoralis presenting as acute abdominal distress under corticosteroid therapy. Rev. Hosp. Clin. Fac. Med. São Paulo 2001, 56:103-106.
334. Rodrigues R.M., de Oliveira M.C., Sopelete M.C., Silva D.A., Campos D.M., Taketomi E.A., Costa-Cruz J.M. IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen. Parasitol. Res. 2007, 101:1209-1214.
335. Rodrigues R.M., Sopelete M.C., Silva D.A., Cunha-Júnior J.P., Taketomi E.A., Costa-Cruz J.M. Strongyloides ratti antigenic components recognized by IgE antibodies in immunoblotting as an additional tool for improving the immunodiagnosis in human strongyloidiasis. Mem. Inst. Oswaldo Cruz 2004, 99:89-93.
336. Roeckel I.E., Lyons E.T. Cutaneous larva migrans, an occupational disease. Ann. Clin. Lab. Sci. 1977, 7:405-410.
337. Roka M., Goñi P., Rubio E., Clavel A. Prevalence of intestinal parasites in HIV-positive patients on the island of Bioko, Equatorial Guinea: its relation to sanitary conditions and socioeconomic factors. Sci. Total Environ. 2012, 432:404-411.
338. Román-Sánchez P., Pastor-Guzmán A., Moreno-Guillén S., Igual-Adell R., Martín-Estruch A., Navarro-Gonzalo I., Ricart-Olmos C. Endemic strongyloidiasis on the Spanish Mediterranean coast. Q. J. Med. 2001, 94:357-363.
339. Román-Sánchez P., Pastor-Guzmán A., Moreno-Guillén S., Igual-Adell R., Suñer-Generoso S., Tornero-Estébanez C. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am. J. Trop. Med. Hyg. 2003, 69:336-340.
340. Romero-Cabello R., Villagroy-Gómez J., Hernández-González M., Romero-Feregrino R. Hyperinfection with Strongyloides stercoralis. BMJ Case Rep. 2012, 30:2012.
341. Ronan S.G., Reddy R.L., Manaligod J.R., Alexander J., Fu T. Disseminated strongyloidiasis presenting as purpura. J. Am. Acad. Dermatol. 1989, 21:1123-1125.
342. Roseman D.A., Kabbani D., Kwah J., Bird D., Ingalls R., Gautam A., Nuhn M., Francis J.M. Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor. Am. J. Transpl. 2013, 13:2483-2486.
343. Rotman H.L., Schnyder-Candrian S., Scott P., Nolan T.J., Schad G.A., Abraham D. IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol. 1997, 19:29-39.
344. Rotman H.L., Yutanawiboonchai W., Brigandi R.A., Leon O., Gleich G.J., Nolan T.J., Schad G.A., Abraham D. Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. Exp. Parasitol. 1996, 82:267-278.
345. Rotman H.L., Yutanawiboonchai W., Brigandi R.A., Leon O., Nolan T.J., Schad G.A., Abraham D. Strongyloides stercoralis: complete life cycle in SCID mice. Exp. Parasitol. 1995, 81:136-139.
346. Royle G., Fraser-Moodie A., Jones M.W. Hyperinfection with Strongyloides stercoralis in Great Britain. Br. J. Surg. 1974, 61:498-500.
347. Ruankham W., Bunchu N., Koychusakun P. Prevalence of helminthic infections and risk factors in villagers of Nanglae Sub-District, Chiang Rai Province, Thailand. J.Med. Assoc. Thai. 2014, 97(Suppl. 4):S29-S35.
348. Russo J.J., Rusiecki R.S., Vincek V., Burt M.J., Rand K. Purpuric eruption in a patient treated with systemic steroids. Arch. Dermatol. 2010, 146:191-196.
349. Sadjadi S.A., Damodaran C., Sharif M. Strongyloides stercoralis infection in transplanted patients. Am. J. Case Rep. 2013, 14:205-209.
350. Safdar A., Malathum K., Rodriguez S.J., Husni R., Rolston K.V. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004, 100:1531-1536.
351. Salim N., Schindler T., Abdul U., Rothen J., Genton B., Lweno O., Mohammed A.S., Masimba J., Kwaba D., Abdulla S., Tanner M., Daubenberger C., Knopp S. Enterobiasis and strongyloidiasis and associated co-infections and morbidity markers in infants, preschool- and school-aged children from rural coastal Tanzania: a cross-sectional study. BMC Infect. Dis. 2014, 14:644.
352. Salluh J.I., Feres G.A., Velasco E., Holanda G.S., Toscano L., Soares M. Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. Intensive Care Med. 2005, 31:1292.
353. Salvador F., Molina I., Sulleiro E., Burgos J., Curran A., Van den Eynde E., Villar del Saz S., Navarro J., Crespo M., Ocaña I., Ribera E., Falcó V., Pahissa A. Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain. Am. J. Trop. Med. Hyg. 2013, 88:1196-1202.
354. Sammet S., Wieser A., Müller S., Huber M., Schubert S., Seybold U. Triple worm infestation in an HIV-infected patient. Infection 2013, 41:1053-1054.
355. Sandlund J.T., Kauffman W., Flynn P.M. Strongyloides stercoralis infection mimicking relapse in a child with small noncleaved cell lymphoma. Am. J. Clin. Oncol. 1997, 20:215-216.
356. Santiago M., Leitão B. Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view. Eur. J. Intern. Med. 2009, 20:744-748.
357. Sarangarajan R., Ranganathan A., Belmonte A.H., Tchertkoff V. Strongyloides stercoralis infection in AIDS. AIDS Patient Care STDS 1997, 11:407-414.
358. Sarubbi F.A. Hyperinfection with Strongyloides during treatment of pemphigus vulgaris. Arch. Dermatol. 1987, 123:864-865.
359. Sato Y., Takara M., Otsuru M. Detection of antibodies in strongyloidiasis by enzyme-linked immunosorbent assay (ELISA). Trans. R. Soc. Trop. Med. Hyg. 1985, 79:51-55.
360. Sato Y., Inoue F., Matsuyama R., Shiroma Y. Immunoblot analysis of anti-bodies in human strongyloidiasis. Trans. R. Soc. Trop. Med. Hyg. 1990, 84:403-406.
361. Sato Y., Inoue F., Kiyuna S., Shiroma Y. Immunoblot analysis of three antigen preparations from Strongyloides stercoralis larvae in human strongyloidiasis. Jpn. J. Parasitol. 1990, 39:258-266.
362. Sato Y., Kobayashi J., Toma H., Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am. J. Trop. Med. Hyg. 1995, 53:248-250.
363. Satoh M., Toma H., Sato Y., Takara M., Shiroma Y., Kiyuna S., Hirayama K. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin. Exp. Immunol. 2002, 127:354-359.
364. Satoh M., Toma H., Sugahara K., Etoh K., Shiroma Y., Kiyuna S., Takara M., Matsuoka M., Yamaguchi K., Nakada K., Fujita K., Kojima S., Hori E., Tanaka Y., Kamihira S., Sato Y., Watanabe T. Reduced efficacy of treatment of strongyloidiasis in HTLV-1 carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin. Exp. Immunol. 2002, 127:354-359.
365. Schad G.A. Morphology and life history of Strongyloides stercoralis. Strongyloidiasis a Major Roundworm Infection of Man 1989, 85-104. Taylor & Francis Ltd, London. I. Grove (Ed.).
366. Schaeffer M.W., Buell J.F., Gupta M., Conway G.D., Akhter S.A., Wagoner L.E. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J. Heart Lung Transpl. 2004, 23:905-911.
367. Schär F., Inpankaew T., Traub R.J., Khieu V., Dalsgaard A., Chimnoi W., Chhoun C., Sok D., Marti H., Muth S., Odermatt P. The prevalence and diversity of intestinal parasitic infections in humans and domestic animals in a rural Cambodian village. Parasitol. Int. 2014, 63:597-603.
368. Schär F., Trostdorf U., Giardina F., Khieu V., Muth S., Marti H., Vounatsou P., Odermatt P. Strongyloides stercoralis: global distribution and risk factors. PLos Negl. Trop. D. 2013, 7:e2288.
369. Scowden E.B., Schaffner W., Stone W.J. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Med. Baltim. 1978, 57:527-544.
370. Seet R.C., Gong L.L., Tambyath P.A. Image of the month. Strongyloides stercoralis hyperinfection and syndrome of inappropriate secretion of antidiuretic hormone. Gastroenterology 2005, 128:8-252.
371. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann. Pharmacother. 2007, 41:1992-2001.
372. Sen P., Gil C., Estrellas B., Middleton J.R. Corticosteroid-induced asthma: a manifestation of limited hyperinfection syndrome due to Strongyloides stercoralis. South Med. J. 1995, 88:923-927.
373. Shelhamer J.H., Neva F.A., Finn D.R. Persistent strongyloidiasis in an immunodeficient patient. Am. J. Trop. Med. Hyg. 1982, 31:746-751.
374. Shields A.M., Goderya R., Atta M., Sinha P. Strongyloides stercoralis hyperinfection presenting as subacute small bowel obstruction following immunosuppressive chemotherapy for multiple myeloma. BMJ Case Rep. 2014, 27:2014.
375. Shorman M., Al-Tawfiq J.A. Strongyloides stercoralis hyperinfection presenting as acute respiratory failure and Gram-negative sepsis in a patient with astrocytoma. Int. J. Infect. Dis. 2009, 13:e288-291.
376. Siddiqui A.A., Gutierrez C., Berk S.L. Diagnosis of Strongyloides stercoralis by acid-gast staining. J. Helminthol. 1999, 73:187-188.
377. Siddiqui A.A., Berk S.L. Diagnosis of Strongyloides stercoralis infection. Clin. Infect. Dis. 2001, 33:1040-1047.
378. Siddiqui A.A., Koenig N.M., Sinensky M., Berk S.L. Strongyloides stercoralis: identification of antigens in natural human infections from endemic areas of the United States. Parasitol. Res. 1997, 83:655-658.
379. Siddiqui A.A., Stanley C.S., Skelly P.J., Berk S.L. A cDNA encoding a nuclear hormone receptor of the steroid/thyroid hormone-receptor superfamily from the human parasitic nematode Strongyloides stercoralis. Parasitol. Res. 2000, 86:24-29.
380. Siegel M.O., Simon G.L. Is human immunodeficiency virus infection a risk factor for Strongyloides stercoralis hyperinfection and dissemination?. PLoS Negl. Trop. Dis. 2012, 6:e1581.
381. da Silva H., de Carvalho C.J., Levenhagen M.A., Costa-Cruz J.M. The detergent fraction is effective in the detection of IgG anti-Strongyloides stercoralis in serum samples from immunocompromised individuals. Parasitol. Int. 2014, 63:790-793.
382. da Silva O.A., Amaral C.F., Da Silveira J.C., López M., Pittella J.E. Hypokalemic respiratory muscle paralysis following Strongyloides stercoralis hyperinfection: a case report. Am. J. Trop. Med. Hyg. 1981, 30:69-73.
383. Silva L.P., Barcelos I.S.C., Passos-Lima A.B., Espindola F.S., Campos D.M.B., Costa-Cruz J.M. Western blotting using Strongyloides ratti antigen for the detection of IgG antibodies as confirmatory test in human strongyloidiasis. Mem. Inst. Oswaldo Cruz 2003, 98:687-691.
384. Silvestri C., Greganti G., Arzeni D., Morciano A., Castelli P., Barchiesi F., Cirioni O., Giacometti A. Intestinal parasitosis: data analysis 2006-2011 in a teaching hospital of Ancona, Italy. Infez. Med. 2013, 21:34-39.
385. Smith B., Verghese A., Guiterrez C., Dralle W., Berk S.L. Pulmonary strongyloidiasis. Diagnosis by sputum gram stain. Am. J. Med. 1985, 79:663-666.
386. Socías M.E., Fernández A., Gil J.F., Krolewiecki A.J. Soil transmitted helminthiasis in Argentina. A systematic review. Med. (B Aires) 2014, 74:29-36.
387. Soonawala D., van Lieshout L., den Boer M.A., Claas E.C., Verweij J.J., Godkewitsch A., Ratering M., Visser L.G. Post-travel screening of asymptomatic long-term travelers to the tropics for intestinal parasites using molecular diagnostics. Am. J. Trop. Med. Hyg. 2014, 90:835-839.
388. Speare R. Identification of species of Strongyloides. Strongyloidiasis a Major Roundworm Infection of Man 1989, 11-84. Taylor & Francis Ltd, London. I. Grove (Ed.).
389. Starr M.C., Montgomery S.P. Soil-transmitted Helminthiasis in the United States: a systematic review-1940-2010. Am. J. Trop. Med. Hyg. 2011, 85:680-684.
390. Stein L.H., Redding K.M., Lee J.J., Nolan T.J., Schad G.A., Lok J.B., Abraham D. Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis. J. Innate Immun. 2009, 1:618-630.
391. Steinmann P., Zhou X.N., Du Z.W., Jiang J.Y., Wang L.B., Wang X.Z., Li L.H., Marti H., Utzinger J. Occurrence of Strongyloides stercoralis in Yunnan Province, China, and comparison of diagnostic methods. PLoS Negl. Trop. Dis. 2007, 1:e75.
392. Steinmann P., Zhou X.N., Du Z.W., Jiang J.Y., Xiao S.H., Wu Z.X., Zhou H., Utzinger J. Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial. PLoS Negl. Trop. Dis. 2008, 2(10):e322. 10.1371/journal.pntd.0000322.
393. Stoltzfus J.D., Bart S.M., Lok J.B. cGMP and NHR signaling co-regulate expression of insulin-like peptides and developmental activation of infective larvae in Strongyloides stercoralis. PLoS Pathog. 2014, 10:e1004235.
394. Stoltzfus J.D., Massey H.C., Nolan T.J., Griffith S.D., Lok J.B. Strongyloides stercoralis age-1: a potential regulator of infective larval development in a parasitic nematode. PLoS One 2012, 7:e38587.
395. Stoltzfus J.D., Minot S., Berriman M., Nolan T.J., Lok J.B. RNAseq analysis of the parasitic nematode Strongyloides stercoralis reveals divergent regulation of canonical dauer pathways. PLoS Negl. Trop. Dis. 2012, 6:e1854.
396. Stothard J.R., Pleasant J., Oguttu D., Adriko M., Galimaka R., Ruggiana A., Kazibwe F., Kabatereine N.B. Strongyloides stercoralis: a field-based survey of mothers and their preschool children using ELISA, Baermann and Koga plate methods reveals low endemicity in western Uganda. J. Helminthol. 2008, 82:263-269.
397. Streit A. Reproduction in Strongyloides (Nematoda): a life between sex and parthenogenesis. Parasitology 2008, 135:285-294.
398. Sudré A.P., Macedo H.W., Peralta R.H.S., Peralta J.M. Diagnóstico da estrongiloidíase humana: importância e técnicas. Rev. Patol. Trop. 2006, 35:174-184.
399. Sudré A.P., Siqueira R.C., Barreto M.G.M., Peralta R.H.S., Macedo H.W., Peralta J.M. Identification of a 26kDa-protein fraction as na important antigen for application in the immunodiagnosis os strongyloidiasis. Parasitol. Res. 2007, 101:1117-1123.
400. Sultana Y., Jeoffreys N., Watts M.R., Gilbert G.L., Lee R. Real-time polymerase chain reaction for detection of Strongyloides stercoralis in stool. Am. J. Trop. Med. Hyg. 2013, 88:1048-1051.
401. Suputtamongkol Y., Premasathian N., Bhumimuang K., Waywa D., Nilganuwong S., Karuphong E., Anekthananon T., Wanachiwanawin D., Silpasakorn S. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl. Trop. Dis. 2011, 5:e1044.
402. Suputtamongkol Y., Kungpanichkul N., Silpasakorn S., Beeching N.J. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. Int. J. Antimicrob. Agents 2008, 31:46-49.
403. Suvajdzic N., Kranjcić-Zec I., Jovanović V., Popović D., Colović M. Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia 1999, 29:323-326.
404. Suzuki T., Nara N., Miyake S., Eishi Y., Sugiyama E., Aoki N. Fatal strongyloidiasis latent over 42 years in the antineoplastic chemotherapy of a case with malignant lymphoma. Jpn. J. Med. 1989, 28:96-99.
405. Sykes A.M., McCarthy J.S. A coproantigen diagnostic test for Strongyloides infection. PLoS Negl. Trop. Dis. 2011, 5:e955.
406. Tabacof J., Feher O., Katz A., Simon S.D., Gansl R.C. Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsis. Cancer 1991, 68:1821-1823.
407. Taha H.A., Soliman M.I., Banjar S.A. Intestinal parasitic infections among expatriateworkers in al-Madina al-Munawarah, Kingdom of Saudi Arabia. Trop. Biomed. 2013, 30:78-88.
408. Takayanagui O.M., Lofrano M.M., Araúgo M.B., Chimelli L. Detection of Strongyloides stercoralis in the cerebrospinal fluid of a patient with acquired immunodeficiency syndrome. Neurology 1995, 45:193-194.
409. Tanaka M., Hirabayashi Y., Gatanaga H., Aizawa S., Hachiya A., Takahashi Y., Tashiro E., Kohsaka T., Oyamada M., Ida S., Oka S. Reduction in interleukin-2-producing cells but not Th1 to Th2 shift in moderate and advanced stagesof human immunodeficiency virus type-1-infection: direct analysis of intracellular cytokine concentrations in CD4+ CD8- T cells. Scand. J. Immunol. 1999, 50:550-554.
410. Taniuchi M., Verweij J.J., Noor Z., Sobuz S.U., Lieshout L., Petri W.A., Haque R., Houpt E.R. High throughput multiplex PCR and probe-based detection with Luminex beads for seven intestinal parasites. Am. J. Trop. Med. Hyg. 2011, 84:332-337.
411. Tanton D.D., Durning S., Chambers S. Pulmonary hyperinfection with Strongyloides stercoralis in an immunocompetent patient. J. Gen. Inter. Med. 2002, 17:72-73.
412. Tarr P.E., Miele P.S., Peregoy K.S., Smith M.A., Neva F.A., Lucey D.R. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am. J. Trop. Med. Hyg. 2003, 68:453-455.
413. Tefé-Silva C., Beneli C.T., Celes M.R., Machado E.R., Ueta M.T., Sorgi C.A., Floriano E.M., Faccioli L.H., Ramos S.G. Dexamethasone reduces bronchial wall remodeling during pulmonary migration of Strongyloides venezuelensis larvae in rats. Parasitol. Int. 2012, 61:425-430.
414. Teklemariam Z., Abate D., Mitiku H., Dessie Y. Prevalence of intestinal parasitic infection among HIV positive persons who are naive and on antiretroviral treatment in Hiwot Fana Specialized University Hospital, Eastern Ethiopia. ISRN AIDS 2013, 11:324329. 10.1155/2013/324329.
415. Ten Hove R.J., Van Esbroeck M., Vervoort T., Van den Ende J., Van Lieshout L., Verweij J.J. Molecular diagnostics of intestinal parasites in returning travellers. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:1045-1053.
416. Thomas M.C., Costello S.A. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int. J. Clin. Pract. 1998, 52:520-521.
417. Thompson B.F., Fry L.C., Wells C.D., Olmos M., Lee D.H., Lazenby A.J., Mönkemüller K.E. The spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest. Endosc. 2004, 59:906-910.
418. Thompson F.J., Barker G.L., Hughes L., Wilkes C.P., Coghill J., Viney M.E. A microarray analysis of gene expression in the free-living stages of the parasitic nematode Strongyloides ratti. BMC Genomics 2006, 7:157.
419. Thompson F.J., Mitreva M., Barker G.L., Martin J., Waterston R.H., McCarter J.P., Viney M.E. An expressed sequence tag analysis of the life-cycle of the parasitic nematode Strongyloides ratti. Mol. Biochem. Parasitol. 2005, 142:32-46.
420. Thompson J.R., Berger R. Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloidiasis. Chest 1991, 99:772-774.
421. Tine R.C., Ndiaye M., Hansson H.H., Ndour C.T., Faye B., Alifrangis M., Sylla K., Ndiaye J.L., Magnussen P., Bygbjerg I.C., Gaye O. The association between malaria parasitaemia, erythrocyte polymorphisms, malnutrition and anaemia in children less than 10years in Senegal: a case control study. BMC Res. Notes 2012, 5:565.
422. Tiwari S., Rautaraya B., Tripathy K.P. Hyperinfection of Strongyloides stercoralis in an immunocompetent patient. Trop. Parasitol. 2012, 2:135-137.
423. Torres J.R., Isturiz R., Murillo J., Guzman M., Contreras R. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin. Infect. Dis. 1993, 17:900-902.
424. Tsai H.C., Lee S.S., Liu Y.C., Lin W.R., Huang C.K., Chen Y.S., Wann S.R., Tsai T.H., Lin H.H., Yen M.Y., Yen C.M., Chen E.R. Clinical manifestations of strongyloidiasis in Southern Taiwan. J. Microbiol. Immunol. Infect. 2002, 35:29-36.
425. Turner S.A., Maclean J.D., Fleckenstein L., Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am. J. Trop. Med. Hyg. 2005, 73:911-914.
426. Uparanukraw P., Phongsri S., Morakote N. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am. J. Trop. Med. Hyg. 1999, 60:967-973.
427. Utzinger J., Becker S.L., Knopp S., Blum J., Neumayr A.L., Keiser J., Hatz C.F. Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med. Wkly. 2012, 142:w13727.
428. Vadlamudi R.S., Chi D.S., Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin. Mol. Allergy 2006, 4:8.
429. Valdez H., Lederman M.M. Cytokines and cytokine therapies in HIV infection. AIDS Clin. Rev. 1997, 1997-1998:187-228.
430. Valerio L., Roure S., Fernández-Rivas G., Basile L., Martínez-Cuevas O., Ballesteros Á.L., Ramos X., Sabrià M., North Metropolitan Working Group on Imported Diseases Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012. Trans. R. Soc. Trop. Med. Hyg. 2013, 107:465-470.
431. Van Doorn H.R., Koelewijn R., Hofwegen H., Gilis H., Wetstayn J.C., Wismans P.J., Sarfati C., Vervoort T., Van Gool T. Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans. J.Clin. Microbiol. 2007, 45:438-442.
432. Van Egmond M., Damen C.A., Van Spriel A.B., Vidarsson G., Van Garderen E., Van de Winkel J.G. IgA and the IgA Fc receptor. Trends Immunol. 2001, 22:205-211.
433. Van Gool T., Weijts R., Lommerse E., Mank T.G. Triple faeces test: an effective tool for detection of intestinal parasites in routine clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:284-290.
434. Vanuytsel T., Sagaert X., Van Dijck H., Vandepitte K., Shea-Donohue T., Tack J., Van den Brande P. An unsuspected cause of diarrhoea and gastrointestinal bleeding during corticosteroid therapy. Acta Gastroenterol. 2014, 77:259-261.
435. Varatharajalu R., Parandaman V., Ndao M., Andersen J.F., Neva F.A. Strongyloides stercoralis excretory/secretory protein strongylastacin specifically recognized by IgE antibodies in infected human sera. Microbiol. Immunol. 2011, 55:115-122.
436. Verhagen L.M., Incani R.N., Franco C.R., Ugarte A., Cadenas Y., Sierra Ruiz C.I., Hermans P.W., Hoek D., Campos Ponce M., de Waard J.H., Pinelli E. High malnutrition rate in Venezuelan Yanomami compared to Warao Amerindians and Creoles: significant associations with intestinal parasites and anemia. PLoS One 2013, 8:e77581.
437. Verweij J.J., Canales M., Polman K., Ziem J., Brienen E.A.T., Polderman A.M., VanLieshout L. Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:342-346.
438. Viney M.E., Lok J.B. Strongyloides spp. WormBook 2007, 23:1-15.
439. Viney M.E., Matthews B.E., Walliker D. On the biological and biochemical nature of clones populations of Strongyloides ratti. J. Helminthol. 1992, 66:45-52.
440. Vitiello M., Shelling M., Camacho I., Milikowski C., Kerdel F.A. Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus foliaceus treatment with mycophenolate mofetil. J. Drugs Dermatol. 2011, 10:418-421.
441. Vonghachack Y., Sayasone S., Bouakhasith D., Taisayavong K., Akkavong K., Odermatt P. Epidemiology of Strongyloides stercoralis on Mekong islands in Southern Laos. Acta Trop. 2015, 141:289-294.
442. Wang C., Xu J., Zhou X., Li J., Yan G., James A.A., Chen X. Strongyloidiasis: an emerging infectious disease in China. Am. J. Trop. Med. Hyg. 2013, 88:420-425.
443. Watts M.R., James G., Sultana Y., Ginn A.N., Outhred A.C., Kong F., Verweij J.J., Iredell J.R., Chen S.C., Lee R. A loop-mediated isothermal amplification (LAMP) assay for Strongyloides stercoralis in stool that uses a visual detection method withSYTO-82 fluorescent dye. Am. J. Trop. Med. Hyg. 2014, 90:306-311.
444. Wegayehu T., Tsalla T., Seifu B., Teklu T. Prevalence of intestinal parasitic infections among highland and lowland dwellers in Gamo area, South Ethiopia. BMC Public Health 2013, 13:151.
445. WHO Deworming for Health and Development. Report of the Third Global Meeting of the Partners for Parasite Control 2005, World Health Organization, Geneva.
446. WHO Preventive Chemotherapy in Human Helminthiasis. Coordinated Use of Antihelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers 2006, World Health Organization, Geneva.
447. Wiria A.E., Wammes L.J., Hamid F., Dekkers O.M., Prasetyani M.A., May L., Kaisar M.M., Verweij J.J., Tamsma J.T., Partono F., Sartono E., Supali T., Yazdanbakhsh M., Smit J.W. Relationship between carotid intima media thickness and helminth infections on Flores Island, Indonesia. PLoS One 2013, 8:e54855.
448. Woll F., Gotuzzo E., Montes M. Strongyloides stercoralis infection complicating the central nervous system. Handb. Clin. Neurol. 2013, 114:229-234.
449. Wolstenholme A., Fairweather I., Prichard R., von Samson-Himmelstjerna G., Sangster N. Drug resistance in veterinary helminths. Trends Parasitol. 2004, 20:469-476.
450. Wong T.Y., Szeto C.C., Lai F.F., Mak C.K., Li P.K. Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents. Nephron 1998, 79:333-336.
451. Woodring J.H., Halfhill H., Berger R., Reed J.C., Moser N. Clinical and imaging features of pulmonary strongyloidiasis. South Med. J. 1996, 89:10-19.
452. Wu T.C., Lei W.Y., Chen M.C., Hu C.T. Strongyloides stercoralis infection: a health issue regarding indigenous people in Taiwan. Trans. R. Soc. Trop. Med. Hyg. 2012, 106:468-472.
453. Wurtz R., Mirot M., Fronda G., Peters C., Kocka F. Short report: gastric infection by Strongyloides stercoralis. Am. J. Trop. Med. Hyg. 1994, 51:339-340.
454. Yap P., Utzinger J., Hattendorf J., Steinmann P. Influence of nutrition on infectionand re-infection with soil-transmitted helminths: a systematic review. Parasite Vectors 2013, 7:229.
455. Ye P., Garvey P.B., Zhang P., Nelson S., Bagby G., Summer W.R., Schwarzenberger P., Shellito J.E., Kolls J.K. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell. Mol. Biol. 2001, 25:335-340.
456. Yee A., Boylen C.T., Noguchi T., Klatt E.C., Sharma O.P. Fatal Strongyloides stercoralis infection in a patient receiving corticosteroids. West J. Med. 1987, 146:363-364.
457. Yelifari L., Bloch P., Magnussen P., van Lieshout L., Dery G., Anemana S., Agongo E., Polderman A.M. Distribution of human Oesophagostomum bifurcum, hookworm and Strongyloides stercoralis infections in northern Ghana. Trans. R. Soc. Trop. Med. Hyg. 2005, 99:32-38.
458. Yoo E.M., Morrison S.L. IgA: an immune glycoprotein. Clin. Immunol. 2005, 116:3-10.
459. Yoshida A., Nagayasu E., Nishimaki A., Sawaguchi A., Yanagawa S., Maruyama H. Transcripts analysis of infective larvae of an intestinal nematode, Strongyloides venezuelensis. Parasitol. Int. 2011, 60:75-83.
460. Yoshida H., Endo H., Tanaka S., Ishikawa A., Kondo H., Nakamura T. Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus. Mod. Rheumatol. 2006, 16:44-47.
461. Yung E.E., Lee C.M., Boys J., Grabo D.J., Buxbaum J.L., Chandrasoma P.T. Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus. Am. J. Trop. Med. Hyg. 2014, 91:806-809.
462. Zerpa R., Blanco Y.E., Náquira C. Ciclo biológico de Strongyloides fuelleborni: imágenes y videos. Rev. Peru. Med. Exp. Salud Pública 2014, 31:390-392.